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ASTHMA 
0 Introduction 
Asthma is a chronic, inflammatory lung disease characterized by 
recurrent breathing problems. People with asthma have acute episodes or 
when the air passages in their lungs get narrower, and breathing becomes 
more difficult. Sometimes episodes of asthma are triggered by allergens, 
although infection, exercise, cold air and other factors are also important 
triggers. 
Asthma is a chronic condition in the airways of your lungs, and it has 
two main components—constriction, the tightening of the muscles 
surrounding the airways, and inflammation, the swelling and Irritation of the 
airways. Constriction and inflammation cause narrowing of the airways, 
which may result in symptoms such as wheezing, coughing, chest tightness, 
or shortness of breath. Furthermore, there is increasing evidence that, if left 
untreated, asthma can cause long-term loss of lung function. When you 
have asthma and are exposed to a trigger, the ainvays leading to the lungs 
become more inflamed or swollen than usual, making it harder for you to 
breathe. The airways also get smaller due to a tightening of the muscles 
surrounding the airways. Finally, the airways can become congested due to 
a build-up of mucus. Various triggers can cause constriction and 
inflammation to occur in your airways, resulting in a flare-up of your asthma 
symptoms. These triggers may include allergies, infections, and strong 
odors or fumes that you may come in contact with at your home or office. 
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Once you are exposed to a trigger and have a reaction, your airways also 
become more sensitive to other triggers. So, it's important to manage your 
asthma every day—even when you are not having a lot of symptoms. 
1. WHAT IS ASTHMA? 
The word asthma originates from an ancient Greek word meaning 
panting. Essentially, asthma is an inability to breathe properly. When any 
person inhales, the air travels through the following stmctures: 
• Air passes into the lungs and flows through progressively smaller 
airways called bronchioles. The lungs contain millions of these 
airways. 
• All bronchioles lead to alveoli, which are microscopic sacs where 
oxygen and carbon dioxide are exchanged. 
Asthma is a chronic condition in v\^ich these airways undergo changes 
when stimulated by allergens or other environmental triggers. Such changes 
appear to be two specific responses: 
(A) The hyperreactive response (also called hyperresponsiveness). 
(B) The inflammatory response. 
These actions in the airway cause patients to cough, wheeze, and 
experience shortness of breath (dyspnea), the classic symptoms of asthma. 
(A) HYPERREACTIVE RESPONSE 
In the hyperreactive response, smooth muscles in the airways 
constrict and narrow excessively in response to inhaled allergens or other 
irritants. It should be noted that the airways in everyone's lungs respond by 
constricting when exposed to allergens or irritants. There are major 
differences, however, in the hyperreactive response the occurs in people 
with asthma: 
• When people without asthma breathe in and out deeply, the airways 
relax and open in order to rid the lungs of the irritant. 
• When people with asthma try to take those same deep breaths, their 
airways do not relax but instead narrow and the patients pant for 
breath. Smooth muscles in the airways of people with asthma may 
have a defect, perhaps a deficiency in a critical chemical that 
prevents the muscles from relaxing. 
(B) INFLAMMATORY RESPONSE 
The hyperreactive stage is followed by the inflammatory response, 
which generally contributes to asthma in the following way: 
• The immune system responds to allergens or other environmental 
triggers by delivering white blood cells and other immune factors to 
the airways. 
• These so-called inflammatory factors cause the airways to swell, to 
fill with fluid, and to produce a thick sticky mucus. 
• This combination of events results in wheezing, breathlessness, 
inability to exhale properly, and a phlegm-producing cough. 
Inflammation appears to be present in the lungs of all patients with 
asthma, even those with mild cases, and plays a key role in all forms of the 
disease. 
2. WHAT ARE THE SYMPTOMS OF ASTHMA ? 
Asthma symptoms vary in severity from occasional mild bouts of 
breathlessness to daily wheezing that persists despite taking large doses of 
medication. After exposure to asthma triggers, symptoms rarely develop 
abruptly but progress over a period of hours or days. In some cases, the 
airways have become seriously obstructed by the time the patient even calls 
the doctor. 
The classic symptoms of an asthma attack are the following: 
• Wheezing when breathing out is nearly always present during an 
attack. Usually the attack begins with wheezing and rapid breathing, 
and, as it becomes more severe, all breathing muscles become 
visibly active. 
• Shortness of breath (dyspnea). Shortness of breath is a major source 
of distress in asthma patients, although severe dyspnea does not 
always reflect a serious attack or reduced lung function. In fact, some 
patients-particularly the elderly-may not experience significant 
dyspnea but still have very poor lung function. 
• Coughing. In some people the first symptom of asthma is a 
nonproductive cough. In fact, in a 2001 survey, 12% of asthma 
patients reported coughing as a significant problem. Patients 
surveyed tended to feel that daytime cough was even more 
distressing than wheezing or sleep disturbances. 
• Chest tightness or pain. Initial chest tightness without any other 
symptoms may be an early indicator of a serious attack. 
• The neck muscles may tighten, and talking may become difficult or 
impossible. 
• Rapid heart rate. 
• Sweating. 
• Chest pain occurs in about three-quarters of patients; it can be very 
severe, although its Intensity is not necessarily related to the severity 
of the asthma attack itself. 
The end of an attack Is often marked by a cough that produces a 
thick, stringy mucus. After an initial acute attack, inflammation persists for 
days to weeks, often without symptoms. (The inflammation itself must still be 
treated, however, because it usually causes relapse.) 
3. CAUSES OF ASTHMA 
Asthma triggers are imtants in the environment that can provoke 
asthma symptoms or attacks. There are many triggers that can aggravate 
asthma symptoms, and they often differ from person to person. You can 
help prevent bothersome asthma symptoms by identifying and avoiding your 
known triggers. In fact, identifying and avoiding triggers should be part of a 
detailed plan of action to successfully help manage your asthma. 
It may not be possible to completely eliminate asthma triggers. You 
should still try to remove as many as possible from your home and work 
surroundings. This can help you enjoy a healthier life with fewer asthma 
symptoms and attacks. 
3.1 GENETIC FACTORS 
About one-third of all persons with asthma share this condition with 
another member of their immediate family. Asthma may be more likely to be 
passed to children from the mother than from the father. Both allergies and 
asthma are strongly associated with hereditary factors and they share 
certain genetic markers, but they are not always inherited together. 
Research, then, on the genetics of these conditions is confusing and 
difficult. 
3.2 FEMALE HORMONES 
Hormones or changes in hormone levels appear to play a role in the 
severity of asthma in women. Menstrual-Related Asthma. Between 30% 
and 40% of women with asthma experience fluctuations in severity that are 
associated with their menstrual cycle. One study indicated that women with 
menstrually associated asthma tended to have the following characteristics: 
Were older. Had asthma for a long time. Had severe asthma attacks that 
were likely to occur three days before and four days into the menstrual 
period. Oral contraceptives (OCs) theoretically should help asthma 
sufferers by leveling out hormonal changes, but they do not appear to have 
much effect. (There have been a few reports of asthma exacerbation with 
OCs, but these are uncommon events.) Asthma during Pregnancy. During 
pregnancy, one-third of asthmatic women suffers more from the condition 
one-third suffers less, and the other third experience no difference in 
severity. One interesting but unsubstantiated study suggests that expectant 
asthmatic mothers carrying a female baby tend to have more severe 
symptoms than do those who are bearing a male. Menopause and Asthma. 
Around the time of menopause (called perimenopause) when estrogen 
declines, the risk for hospitalization in women with asthma increases 
fourfold compared to previous years. Although it should then follow that 
hormone replacement therapy (HRT), which contains estrogen, should 
benefit postmenopausal women studies are inconsistent. As with OCs, if 
there is an effect one way or the other, it is likely to be weak. 
3.3 NSAIDS AND ACETAMINOPHEN 
Aspirin-Induced Asthma. About 10% of asthmatic adults and some 
fewer children have aspirin-induced asthma (AIA). With this condition, 
asthma gets worse when patients take aspirin. Although aspirin Is used to 
reduce inflammation in other disorders, it appears to have the opposite 
effect in many asthma cases. It is not wholly known why this occurs. AIA 
often develops after a viral infection. It is a particulariy severe asthmatic 
condition and is associated with up to 25% of asthma-related 
hospitalizations. In about 5% of cases, aspirin is responsible for a syndrome 
that involves multiple attacks of asthma, sinusitis, and nasal congestion. 
Such patients also often have polyps (small benign growths) in the nasal 
passages. Alternative Agents. Patients with aspirin-induced asthma (AIA) 
should avoid aspirin and most likely other non-steroidal anti-inflammatory 
agents (NSAIDs), including ibuprofen (Advil) and naproxen (Aleve). 
Acetaminophen (e.g., Tylenol) has been the traditional alternative for relief 
of minor pain. Unfortunately, recent evidence has muddied these 
recommendations. Some evidence has linked asthmatic responses to high 
consumption of acetaminophen-called paracetamol in Europe among adults. 
And a study of children with asthma reported that those who took ibuprofen 
were less likely to be hospitalized for asthma than those taking 
acetaminophen. Whether these results apply to children or adults who are 
aspirin sensitive is unknown, however. Experts hope that the new NSAIDs 
COX-2 inhibitors, which include celecoxib (Celebrex) and rofecoxib (Vioxx), 
may be safe for AIA. To date, studies are promising but more research is 
needed to confirm their safety in people with this condition. 
3.4 CONTRIBUTING MEDICAL CONDITIONS 
Infections. The role of infections in asthma is complicated. 
Respiratory infections may play a role in some cases of adult-onset asthma, 
but may be protective against asthma in small children. Researchers are 
particularly interested in the organisms Chlamydia pneumoniae, 
Mycoplasma pneumoniae, adenovirus, and the respiratory syncytial virus. 
They are major causes of both mild and serious respiratory infections and 
are becoming important suspects in many cases of severe adult asthma. (If 
such respiratory infections occur in young children, they are unlikely to have 
any affect on adult-onset asthma.) In one study, patients whose asthma 
was initiated after infections had more severe conditions than those whose 
asthma was due to other causes. The infection-initiated asthma, however, 
lasted only 5.6 years compared to 13.3 years in the non-infection group. In 
any age group, respiratory infections worsen existing asthma in people who 
have it already. Rhinovirus (the common cold virus) has been reported to be 
the most common infectious agent associated with asthma attacks. In one 
study, it was associated with 61% of asthma exacerbations in children and 
44% in adults. Some research suggests that colds promote allergic 
inflammation and increase the intensity of airway responsiveness for weeks. 
GERD. At least half of asthmatic patients also have gastroesophageal reflux 
disease (GERD), the cause of heartburn. It is not entirely clear which 
condition causes the other or whether they are both due to common factors. 
Some theories for the causal connection between GERD and asthma are as 
follows: Acid leaking from the lower esophagus In GERD stimulates the 
vagus nerves , which mn through the gastrointestinal tract. These 
stimulated nerves in turn trigger the nearby airways in the lung to constrict, 
which causes asthma symptoms. Acid back-up that reaches the mouth may 
be inhaled into the airways ( aspirated). Here, the acid triggers a reaction in 
the airways that cause asthma symptoms. GERD is sometimes hard to 
detect and might be suspected as a contributor in the following asthmatic 
patients: Those who do not respond to asthma treatments. Those whose 
asthma attacks follow episodes of heartburn. Those v^ose attacks are 
worse after eating or exercise. Those whose coughs follow episodes of 
acid reflux. (One study found that GERD was associated with about half of 
the episodes of coughs and wheezes in asthmatic patients.) Treating 
GERD symptoms with anti-acid agents resolves asthma in some (but not ail) 
patients who share both conditions. Sinusitis. Almost half of children and 
adults with allergic asthma have sinus abnormalities, and in various studies, 
between 17% and 30% of asthmatic patients develop true sinusitis. The 
presence of sinusitis, however, does not appear to increase the severity of 
asthma. 
3.5 SMOKING 
• Do not allow smoking in the home or around you, especially in the 
bedroom or a car. 
• Avoid smoke-filled areas. 
3.6 DUST MITES 
Dust mites are tiny bugs you cannot see that live in cloth and carpet. 
• Encase your mattress and pillow in a special dust-proof cover. 
• Replace old pillows with new ones at least once every 5 years. 
• Wash the sheets and blankets on the bed each week in hot water. 
Water must be hotter than 130° F (this kills dust mites). 
• During the day, keep dust off your bed by covering the entire bed 
with a bedspread. At night, take off the bedspread and put it in 
another room. 
• If you've done all these things and still have trouble with your asthma, 
talk to your healthcare professional. 
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3.7 PETS 
Some people are allergic to the flakes of skin (dander) or dried saliva 
that come from animals with fur or feathers. 
• Find a new home for the pet or keep pets out of your home. This can 
be very hard to do but might be the best way to control your asthma if 
you are allergic to animals. 
• If you cannot keep pets out of your home, keep the pet out of your 
bedroom and keep the bedroom door closed. 
• Consider placing filters on the air vents in your bedroom. 
• Remove carpets and furniture covered with cloth from your home. If 
this is not possible, keep the pet out of the rooms where these are 
located. 
3.8 COCKROACHES 
Many people with asthma are allergic to the dried droppings and 
remains of cockroaches. 
Keep all food out of your bedroom. Keep food and garbage in closed 
containers (never leave food out). Use baits or traps to eliminate 
cockroaches. If a spray is used to kill roaches, stay out of the room until the 
odor goes away, indoor mold Fix leaky faucets, pipes, or other sources of 
water. Clean mold off of surfaces with a cleaner that has bleach in it. 
Replace or wash moldy shower curtains, smoke, strong odors, and sprays 
If possible, do not use a wood-burning stove, kerosene heater, or fireplace. 
Try to stay away from strong odors and sprays, such as perfume, talcum 
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powder, hair spray, and paints, pollen or outdoor mold During your allergy 
season, you should: Try to keep your windows closed. Stay indoors with 
the windows closed during the midday and afternoon, if you can. Pollen and 
some mold spore counts are highest at that time. Ask your healthcare 
professional whether you need to adjust your current asthma treatment 
regimen before your allergy season starts. Activity If you have asthma, 
you can still be active. See your healthcare professional if you have asthma 
symptoms when you are active—like when you exercise, do sports, play, or 
work hard. Ask your healthcare professional about taking medicine for your 
asthma before you exercise to prevent symptoms. Warm up for about 6 to 
10 minutes before you exercise by stretching or walking. Try not to work or 
play hard outside when the air pollution or pollen levels (if you are allergic to 
pollen) are high. Colds and infections If colds and infections trigger your 
asthma, talk with your healthcare professional about developing a treatment 
plan to follow when you start feeling sick. Also consider: Getting a flu shot 
Trying to stay healthy by getting plenty of rest, eating a balanced diet, 
exercising regularly, drinking plenty of fluids, and avoiding contact with 
others who have colds or the flu. Weather Cover your nose and mouth with 
a scarf on cold or windy days. Avoid going outside on days when pollen or 
mold counts are high if you are allergic to pollens or molds (check weather 
reports or the newspaper). Other triggers Sulfites in foods: For example, 
do not drink beer or wine, and do not eat shrimp, dried fruit, or processed 
potatoes if they cause asthma symptoms. Other medicines: Tell your 
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healthcare professional about all the medicines you may take, include 
aspirin, cold medicines, nonsteroidals (e.g., ibuprofen, naproxen), and even 
eye drops. 
4. TYPES OF ASTHMA 
Asthma is often put into categories or groups based on the "triggers" 
that cause the asthma symptoms or attacks. These categories or types of 
asthma are: 
4.1 ALLERGIC ASTHMA 
Allergic asthma is triggered by an allergic reaction to allergens such as 
pollens or pet dander. People with this type of asthma typically have a 
personal and/or family history of allergies (such as hay fever) and/or 
eczema (skin problem resulting in itching, a red rash, and sometimes small 
blisters). 
4.2 SEASONAL ASTHMA 
Seasonal asthma, a form of allergic asthma, can be triggered by trees, 
grasses, or flowers releasing pollen into the air. For example, some people 
find that their asthma is worse in the spring when there is an increase in 
flowering plants. Others find their asthma is worse in the late summer or 
early fall when ragweed and mold from leaves on trees are more likely to 
cause problems. 
4.3 NONALLERGIC ASTHMA 
For some people with asthma, asthma attacks have nothing to do 
with allergies. Although these people get the same symptoms and have 
13 
similar changes in their airways as patients with allergic asthma, their 
asthma is not triggered by allergies. However, like any patient with asthma, 
asthma attacks may be triggered or made worse by one or more nonallergic 
asthma triggers including materials (irritants) in the air you breathe, such as 
tobacco smoke, wood smoke, room deodorizers, pine odors, fresh paint, 
household cleaning products, cooking odors, workplace chemicals, 
perfumes, and outdoor air pollution. Respiratory infections, such as the 
common cold, the flu, or a sinus infection may also give you symptoms. 
Finally, exercise, cold air, sudden changes in air temperature, and even 
gastroesophageal reflux (heartburn) may be triggers for people with non-
allergic asthma. 
4.4 EXERCISE-INDUCED ASTHMA 
Exercise-induced asthma (EIA) simply refers to asthma symptoms 
that are triggered by exercise or physical activity. These symptoms are 
usually noticed during or shortly after exercise. Exercising outdoors in the 
winter seems to be particularly bad for patients with this type of asthma. 
4.5 NOCTURNAL ASTHMA 
Can occur in a patient with any type of asthma. It refers to asthma 
symptoms that seem worse in the middle of the night, typically between 2 
and 4 AM.Things that can cause asthma symptoms to get worse at night 
may include sinus infections or postnasal drip caused by allergens like dust 
mites or pet dander. Your body clock may also play some role: levels of 
substances your body makes like adrenaline and steroids, both of which 
protect against asthma, are lowest between 4 and 8 AM, making it easier for 
people with asthma to get symptoms during these times. 
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5. HOW SERIOUS IS ASTHMA? 
5.1 Hospitalization and IVIortality Rates 
The number of deaths from asthma increased from about 2,900 in 
1908 to a high of 5,667 in 1996. The numbers appear to be declining 
slightly, and in 1999 about 4,600 people died because of asthma. Death 
from asthma is still a very uncommon event, considering that about 14 
million people in the US have this condition. Most deaths from asthma, even 
\Artien they occur in elderly adults are preventable. It is very rare for a person 
who is receiving proper treatment to die of asthma. And studies suggest that 
the use of inhaled corticosteroids can reduce the risk for death by 90%. In 
spite of this and similar research, these important drugs are greatly 
underused. 
5.2 Risk Factors for Very Severe or Fatal Asthma 
About 55% of US deaths from asthma occur among the elderly (over 
65) and an estimated 25% occur in adults aged 45 to 64. Women have a 
higher risk for fatal asthma than men do. Being poor is also a significant risk 
factor for severe asthma. Hispanics and African Americans are at higher risk 
for death from asthma than Caucasians. Other specific risk factors for fatal 
asthma have been identified: Previous history of respiratory failure. 
Frequent visits to the emergency room. Lack of continuous care and poor 
compliance with medications. Having stopped treatment, particulariy 
withdrawal from corticosteroids. Having an emotional or psychiatric 
disorder. (Some evidence suggests that depression, anxiety, and stressful 
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life situations can worsen asthma.) Being a drug abuser. Being in a lower 
socioeconomic and educational group. 
5.3 Symptoms of a Life-Threatening Attacic 
Following signs and symptoms may indicate a life-threatening 
situation: As the chest labors to bring enough air into the lungs, breathing 
often becomes shallow. Lacking suificient oxygen, the skin becomes bluish. 
The flesh around the ribs of the chest appears to be sucked in. The patient 
may begin to lose consciousness. Asthma often progresses very slowly to a 
serious condition or may develop to a fatal or near-fatal attack within a few 
minutes. It is very difficult to predict when an attack will become very 
serious. It should be noted that early symptoms or lack of them do not 
always reflect the ultimate severity of an attack. In fact, some studies 
suggest that people at high risk for fatal or near-fatal asthma attacks are 
those with poor awareness of their own reduced ability to breathe and who 
are therefore slow in seeking help. Monitoring peak flow rates is, therefore, 
an important management component, since it provides a more accurate 
assessment of lung function than symptoms alone. 
5.4 Degree of Severity 
The severity of asthma is graded using the following categories: mild 
intermittent and mild, moderate, and severe persistent. It should be noted 
that a patient in any of these categories, even mild intermittent, can still 
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experience a severe and even life-threatening attack. In fact, according to 
one report, 30% of asthma deaths occur in patients with mild asthma. 
6.5 Long-Term Outlook 
Asthma is usually chronic, although it occasionally goes into long 
periods of remission. Long-term outlook generally depends on severity: In 
mild to moderate cases, asthma can improve over time, and many adults 
even become symptom free. Even in some severe cases, adults may 
experience improvement depending on the degree of obstruction in the 
lungs and the timeliness and effectiveness of treatment. In about 10% of 
severe persistent cases, changes in the structure of the walls of the airways 
lead to progressive and irreversible problems in lung function, even in 
aggressively treated patients. Lung function in any case declines faster 
than average in asthmatics, particularly in those who smoke and in those 
with excessive mucus production (an indicator of poor treatment control). 
Overall, one study reported that 72% of men and 86% of women with 
asthma had symptoms fifteen years after an initial diagnosis. Only 19% of 
these people, however, were still seeing a doctor and only 32% used any 
maintenance medication. Of note are patients who develop occupational 
asthma. They often experience asthmatic symptoms for years, even after 
avoiding the harmful agents, although improvement occurs over time in most 
people who leave such jobs. 
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5.6 Miscellaneous Complications or Associations 
Emotional Problems. Even when it is not life threatening, asthma is 
debilitating and frightening. It significantly lowers the quality of life. Sleep 
Disorders. Sleeplessness and daytime sleepiness are common problems. 
Studies indicate that between 80% and 93% of asthmatics have sleeping 
problems about three times a week. In one poll, 40% missed work an 
average of 11 days a year because of sleep disturbance. Asthma has been 
associated with snoring and obstructive sleep apnea, a condition in which 
blod^age of the upper airway causes the sleeper to temporarily stop 
breathing, then resume with a gasp, often many times during each hour of 
sleep. Asthma arid Pregnancy. Uncontrolled asthma in pregnant women 
puts them at higher risk for complications that can include early labor, 
hypertension, gestational diabetes, and hemorrhage. Asthma also places 
the babies at risk for lower birth weight and breathing disorders. Teenage 
mothers with asthma face higher risks than older women. Fortunately, 
studies indicate that most asthma drugs are safe to take during pregnancy, 
and good control of asthma reduces these risks to normal levels. 
' Fortunately, a number of asthma medications are safe during pregnancy. 
Heart Disease. There have been some reports of an association between 
asthma and a heightened risk for heart disease. Some experts believe that 
the inflammatory process may be the common factor linking the two 
conditions, although there is no evidence to date confirming any causal 
association. 
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6. WHICH ADULTS ARE AT RISK FOR ASTHMA? 
6.1 General Risk Factors 
According to a major national 2001 survey, American adults have a 
10% lifetime risk for developing asthma. As of 2000, an estimated 14.6 
million adults had the disorder. Between 1980 and 1996 the prevalence of 
asthma increased by nearly 74%, but it may be stabilizing. Other respiratory 
diseases, sinusitis, and ear infections are also on the rise, suggesting that 
airborne or environmental factors may be at work that affect all of these 
conditions, including asthma. 
6.2 Gender 
Before puberty, asthma occurs more often in males, but after 
adolescence, it appears to be more common in females. In adults with 
similar cases of actual air way obstruction, women are likely to report more 
severe symptoms than men are. In addition, women may be at much greater 
risk of death from asthma than men. 
6.3 Obesity 
In both adults and children, the incidence of obesity and asthma has 
been increasing in parallel over recent years. Studies report a strong 
association between the two conditions. Some experts suggest that excess 
weight pressing on the lungs may trigger the hyper reactive response in the 
airways typical of asthma. Others believe that asthma leads to obesity by 
inhibiting physical activity, although studies in 2000 and 2001 found no 
difference in activity levels between people with or without asthma. One 
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2000 study suggested that many obese people may be misdiagnosed as 
having asthma when in fact they are simply short of breath, possibly 
because of the increased effort required for breathing. 
In any case, there is some evidence that losing weight can relieve 
asthma symptoms. Weight loss in anyone who is obese and has asthma or 
shortness of breath reduces airway obstruction and improves lung function. 
6.4 Smoking 
In one study of elderly people with severe adult-onset asthma, 
smoking was the most significant risk factor for developing this condition. 
Smoking, in any case, contributes to decline in lung function in everyone. 
6.5 Population Differences 
Urban Life and Poverty. African Americans have higher rates of 
asthma than Caucasian Americans or other ethnic groups. They are also 
more likely to die of the disease. Ethnicity and genetics, however, are less 
likely to play a role in these differences than socioeconomic differences, 
such as having less access to optimal health care. Poverty is a consistent 
risk factor in most studies. Both the elderly and the urban poor have the 
highest risk for severe asthma and death. Urban life, in fact, has been 
associated with a higher risk for asthma in all income groups and among 
both children and adults. Twin studies also suggest that people who have 
lower educational levels (as well as those who exercise less) are at higher 
risk for adult-onset asthma, further suggesting a link to lower economic 
status. 
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7. WHAT TESTS MAY BE REQUIRED TO DIAGNOSE 
ASTHMA? 
7.1 Medical and Personal History 
When asthma is suspected, the patient should describe for the 
physician any pattern related to the symptoms and possible precipitating 
factors, including the following: 
• Whether symptoms are more frequent during the spring or fall 
(allergy seasons). 
• Whether exercise, a respiratory infection, or exposure to cold air has 
ever triggered an attack. 
• Any family history of asthma or allergic disorders, such as eczema, 
hives, or hay fever. 
• Any occupational or long-term exposure to chemicals. Early detection 
of occupational asthma is very important. If symptoms improve on 
weekends and vacation and are worse at work, the job is likely to be 
the source of the asthma, although this is not always the case. 
Asthma is common, and exacerbation at work may be coincidental. 
7.2 Ruling Out Other Diseases 
A number of disorders may cause some or all of the symptoms of 
asthma: Asthma and chronic obstructive lung diseases (chronic bronchitis 
and emphysema) affect the lungs in similar ways and, in fact, may all be 
present in the same person. Unlike the other chronic lung conditions, 
asthma usually first appears in patients less than 30 years old and with 
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chest x-rays that are normal. Still, it may be difficult to distinguish these 
disorders in some adults with late onset asthma. 
• Panic disorder can coincide with asthma or be confused with it. 
• Gastroesophageal reflux disorder (GERD) is a common companion in 
asthma and may affect treatment. 
• Other diseases that must be considered during diagnosis are 
pneumonia, bronchitis, severe allergic reactions, pulmonary 
embolism, cancer, heart failure, tumors, psychosomatic illnesses, and 
certain rare disorders (such as tapeworm and trichomoniasis). 
7.3 Pulmonary Function Tests 
If symptoms and a patient's history are indicative of asthma, the 
physician will usually perform tests known as pulmonary function tests to 
confirm the diagnosis and determine the severity of the disease. 
Using a spirometer, an instrument that measures the air taken into and 
exhaled from the lungs, the physician will determine several values: 
1. Vital capacity (VC), which is the maximum volume of air that can be 
inhaled or exhaled. 
2. Peak expiratory flow rate (PEFR), commonly called the peak flow rate, 
which is the maximum flow rate that can be generated during a forced 
exhalation. 
3. Forced expiratory volume (FEV1), which is the maximum volume of air 
expired in one second. 
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If the airways are obstructed, then these measurements will fall. Depending 
on the results, the physician will take the following steps: 
• If measurements fall, then the physical typically asks the patient to 
inhale a bronchodilator. This is a drug that is used in asthma to open 
the air passages. The measurements are taken again. If the 
measurements are more normal, than the drug has most likely 
cleared the airways and a diagnosis of asthma is strongly suspected. 
• If measurement results fail to show airway obstruction, but the doctor 
still suspects' asthma, he or she may perform a challenge test. In this 
case a specific drug (histamine or methacholine) is administered that 
usually increases airway resistance only when asthma is present. 
The challenge test may be quite useful in ruling out occupational 
asthma. It is not always accurate, particularly in asthmatic patients 
whose only symptom is persistent coughing. 
• Method for inducing airway resistance is to administer cold air. This 
test is very accurate for ruling out asthma, but it is not sensitive 
enough to accurately identify adults who actually are asthmatic. 
7.4 Allergy Tests 
The patient may be given skin or blood allergy tests, particularly if a 
specific allergen or occupational agent is suspected and available for 
testing. Allergy skin tests may be the best predictive test for allergic asthma, 
although they are not recommended for people with year-round asthma. 
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7.8 Other Tests 
Tests that either rule out other diseases or obtain more information 
about the causes of asthma include the following: 
• A complete blood count. 
• Chest and sinus x-rays. 
• Examination of the patients sputum for eosinophils (white blood cells 
that in high levels are associated with severe allergic asthma). 
• Investigative measurements of markers of airway inflammation, either 
in sputum or in exhaled air. Markers include nitric oxide and 
hydrogen peroxide. (It is not clear yet whether they will be useful in 
assessing.) 
• If aspirin-induced asthma (AIA) is suspected, an investigative non-
invasive test called acoustic rhinometry may be useful. A solution of 
lysine acetylsalicylic acid (L-ASA) is instilled into the patient's nostril. 
Patients who experience symptoms such as sneezing, itching, 
congestion, and secretion are likely to have AIA. rates are 
dramatically higher in New York Puerto Ricans than in Hispanic-
Americans who live in Los Angeles or the Southwest. Among the US 
states, rates are lowest in Louisiana and highest in Maine. And, there 
are significant differences even among nations. In a major study of 22 
nations published in 2001, the countries with the highest asthma 
rates were Britain, Ireland, Australia, New Zealand, and the US. 
(According to another study, asthma rates are also significantly 
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higher in Canadian adults than they are in comparable European 
groups.) Low rates were reported in Iceland, Norway, Spain, 
Germany, Italy, Algeria, India, and Eastern European nations. The 
reasons for these variations are still unknown. 
8. WHAT ARE THE SPECIFIC DRUGS USED TO TREAT 
SYMPTOMS OF ACUTE ASTHMA ATTACKS? 
8.1 Short-Acting Beta2-Agonlsts 
Beta2-agonists do not reduce inflammation or ainvay responsiveness 
but serve as bronchodilators , relaxing and opening constricted airways 
during an acute asthma attack. They are used alone only for patients with 
mild and intermittent asthma. Patients with more severe cases should use 
them in combination with other agents. 
Specific short-acting beta2-agonists include the following: 
• Albuterol (Proventil, Ventolin), called salbutamol outside the US, is 
the standard short-acting beta2-agonist in America. Other similar 
beta2-agonists are isoproterenol (Isuprel, Norisodrine, Medihaler-
Iso), metaproterenol (Alupent, Metaprel), pirbuterol (Maxair), 
terbutaline (Brethine, Brethaire, Bricanyl), and bitolterol (Tornalate). 
Isoetharine (Bronkometer, Bronkosol is available in nebulizers. 
• Newer beta2-agonists, including levalbuterol (Xopenex), have more 
specific actions than the standard agents. Studies have indicated that 
levalbuterol is as effective as albuterol with fewer side effects. 
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Xopenex is administered with a nebulizer and is available without 
preservatives. (It is very expensive, however.) 
Short-acting bronchodilators are generally administered through 
inhalation and are effective for three to six hours. They relieve the 
symptoms of acute attacks, but they do not control the underlying 
inflammation. If asthma continues to worsen with the use of these agents, 
then patients should discuss corticosteroids or other drugs to treat 
underlying inflammation. 
Side Effects of Beta2-Agonists. Side effects of ail beta2-agonists 
include the following: 
• Anxiety. 
• Tremor. 
• Restlessness. 
• Headadie. 
• Patients may experience fast and irregular heartbeats. A physician 
should be notified immediately if such side effects occur, particularly 
in people with existing heart conditions. Such patients face an 
increased risk for sudden death from cardiac related causes. This 
risk is higher with oral or nebulized agents, but there have also been 
reports of heart attacks and angina in some patients using inhaled 
beta2 agonists. 
Beta2-agonists have serious interactions with certain other drugs, 
such as beta-blockers, and patients should tell the physician about any 
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other medications they are taking. Individuals with diabetes, existing heart 
disease, high blood pressure, hyperthyroidism, an enlarged prostate, or a 
history of seizures should take these drugs with caution. 
Loss of Effectiveness and Overdose. There has been some concern 
that both short-acting beta2-agonists become less effective when taken 
regularly over time, increasing the risk for overuse. Over time some patients 
may become tolerant to many effects of short-acting beta2-agonists. The 
degree to which this affects the airways is uncertain. In some studies, the 
duration of action has declined but the peak effect appears to be preserved, 
making these drugs still useful for acute attacks. Regular use of long-acting 
beta 2 agonists may reduce the effect of short-acting forms. 
It's a major concern that patients who perceive beta2 agonists as 
being less effective may over-use them. Overdose can be serious and In 
rare cases even life-threatening, particularly in patients with heart disease. 
8.2 Theophylline And Similar Agents 
Theophylline. Theophylline (Theo-Dur, Theolair, Slo-Phyllin, Slo-bid, 
Constant-T, Respbid) relaxes the muscles around the bronchioles and also 
stimulates breathing. One study reported that it may also have anti-
inflammatory qualities even in low doses. Available in tablet, liquid, and 
injectable forms, some theophylline sustained-release tablets and capsules 
have a long duration of action and can therefore be taken once or twice a 
day with good results. 
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It does have some problems, however; If theophylline Is not taken 
exactly as presCTlbed, an overdose can easily occur. Toxicity causes the 
following symptoms: nausea, vomiting, headache, insomnia, and, in rare 
cases, disturbances in heart rhythm and convulsions. A physician should be 
contacted immediately if any of these side effects occur. 
The risks for these adverse effects are small if the drug is taken exactly 
as prescribed but the following precautions should be noted: 
• Chronic smokers metabolize theophylline much more quickly and 
require higher doses of the drug than nonsmokers; prolonged-release 
versions are helpful for such people. 
• Too much caffeine can increase the concentration of this drug and 
the amount of time it stays in the body. 
• Theophylline also interacts with many other dmgs that are taken for 
other common medical conditions, including asthma. Caution should 
be exercised if beta2-agonists and theophylline are used together. 
• Theophylline should not be taken by anyone who has a peptic ulcer 
and should be taken with caution by the elderly and by individuals 
with heart disease, liver disease, hypertension, seizure disorders, or 
congestive heart failure. Of special note, people with heart conditions 
who take theophylline orally face an increased risk for sudden death 
from heart-related causes. 
Xanthines. Drugs similar to theophylline called xanthines, such as 
doxofylline, may prove to be effective bronchodilators without the adverse 
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effects on the heart that theophylline and beta2 agonists have. More 
research is needed. 
8.3 Anticholinergic Agents 
Inhaled ipratropium bromide (Atrovent) acts as a bronchodilator over 
time. Ipratropium bromide alone is only modestly beneficial for acute asthma 
attacks. In fact, the drug is not approved specifically for asthma. It may, 
however, have benefits in certain cases: 
• It may be useful for certain older asthma patients vrtio also have 
emphysema or chronic bronchitis. 
• A combination with a beta2-agonist might be helpful for patients who 
do not initially respond to treatment with a beta2-agonist alone. 
8.4 What Are The General Guidelines For Treating Asthma 
Emergency Treatment For An Acute Attack ? 
8.4.1 Treating an Acute Attack in ttie Hospital. An acute attack may 
require hospitalization. Laboratory tests, an electrocardiogram (ECG), and a 
chest x-ray are performed to determine lung function, oxygen levels, and 
other indications of severity or rule out other causes. Depending on the 
results, the following treatments may be given: 
• Beta2-agonists are the standard therapy. They may be administered 
with a nebulizer (a device that administers the drug in a fine spray) or 
inhaled hourly. 
• A corticosteroid (commonly called a steroid) is usually given if the 
patient does not respond to beta2-agonist.treatments. They may be 
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given intravenously or orally. Unfortunately, according to one study, 
almost one in four adolescents who are hospitalized due to 
uncontrollable asthma do not respond to steroid treatment. Of some 
promise are reports intravenous immunoglobulin may be effective in 
such patients. 
• Antibiotics may be given if sinusitis, pneumonia, or bronchitis is 
suspected or present. 
• Oxygen is usually administered, and can be life saving in severe 
cases. Some studies report that a mixture of helium and oxygen 
(heliox) may be beneficial. Nevertheless, patients reported 
significantly less breathlessness with the heliox. 
• In life-threatening situations, the patient may require mechanical 
ventilation. 
8.4.2 Discharge and Relapse After Hospitalization. It typically takes 
about three to four hours to determine if a patient can be safely sent home 
or if they need to stay. Patients are generally discharged under the following 
circumstances: 
• When symptoms are gone or minimal, and 
• The peak expiratory flow rate is 70% or more of the predicted rate. 
Discharged patients generally take oral corticosteroids for five to seven 
days. Despite reasonable precautions, about 20% of patients relapse within 
two weeks, although the risk is very low if they keep taking their medication 
after they leave. 
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8.5 Guidelines For Treating Asthma At l-lome 
Avoiding allergens, following appropriate drug treatments, and home 
monitoring are key elements in preventing dangerous asthma attacks and 
hospitalization. A combination of medications is important and effective for 
both treating and preventing asthma attacks. In addition, good 
communication between the physician and patients is a key factor in a 
successful management program. 
Understanding the Difference between Treating Symptoms and 
Controlling the Disease 
Patients can greatly reduce the frequency and severity of asthma 
attacks by understanding the difference between coping with asthma attacks 
and controlling the disease over time. According to a few studies, most 
patients do not discriminate between medications that provide rapid short 
term relief and long term symptom control. 
Medications for asthma are categorized by their ability to achieve either of 
the following: 
• Drugs used to relieve acute asthma symptoms. Anyone experiencing 
a moderate or severe asthma attack should promptly be given 
medications that open the airways. Generally, these are 
bronchodilator called short-acting beta-adrenergic agonists (beta2-
agonists). Others sometimes used in special cases include 
theophylline, and certain anticholinergic agents. None of these 
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agents have any effect on the disease process itself. They are only 
useful for treating symptoms. 
• Drugs used to control long-term persistent inflammation and prevent 
lung injury. For long-term control of the disease, patients with 
moderate to severe asthma require medications to control 
inflammation. Typically, these are patients who are taking the short-
acting beta2 agonists more than twice a week. The standard agents 
for maintenance treatments are inhaled corticosteroids (commonly 
called steroids). Others include leukotriene-antagonists, and 
cromolyn. Combinations of steroids and other medications (such as 
long-acting beta2 agonists or leukotriene-antagonists) are proving to 
be effective for both treating and preventing asthma attacks in 
patients with moderate to severe asthma. 
Simply coping with asthma symptoms without also controlling the 
Inflammation is a common and serious error. Unfortunately, studies are 
finding that a significant number of moderate or severely asthmatic patients 
overuse their inhaled beta-agonists and underuse their corticosteroid 
medications. Such patients, then, are not controlling the basic disease 
process that can lead to lung damage. They also tend to over-use their 
bronchodilators, which can have serious consequences. Furthermore, the 
patients who underuse steroids tend to be elderly, the group at highest risk 
for severe asthma. 
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8.6 Administering inhaied Drugs 
Most asthma drugs are inhaled using special devices or nebulizers. 
The standard inhalers have used ozone-depleting chlorofluorocarbons as 
propellants, but alternative delivery methods and propellants are 
increasingly available that do not threaten the environment and may even 
be better in delivering the drugs. 
8.6.1 Metered'Dose Inhaler. The standard device for administering asthma 
medication has been the metered-dose inhaler (MDI). This device allows 
precise doses to be delivered directly to the lungs. Until recently, MDIs have 
used chlorofluorocarbons (CFCs) as their propellants, which are damaging 
to the environment. 
Many devices now use propellants (e.g., hydrofluoroalkane) that are 
equally effective to CFCs and are environmentally safe. They also do not 
chill the device as CFCs do. Some of the non-CFC inhalers (such as 
Respimat, which uses a soft-mist spray) may be more effective at delivering 
medications than the new dry-powder inhalers . 
The holding chambers for the MDIs also vary in their ability to deliver 
medication. For example, in one study the AiroChamber-Plus was more 
effective than the EasiVent in delivering an inhaled steroid. 
MDI-delivered drugs must be used regularly as prescribed and the patient 
carefully trained in their use in order for them to be effective and safe. Some 
patients hold the MDI too close to their mouths, or even inside them; others 
may exhale too forcefully before inhalation. Often, the devices continue to 
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deliver propellant after the drug has been used up. Patients should track 
their medicine and throw the device away when the last dose has been 
administered. 
8.6.2 Dry Powder Inhalers. Dry powder inhalers (DPIs) deliver a powdered 
form of medications directly into the lungs and do not threaten the 
environment. Such devices include Rotahaler, Spinhaler, Turbohaler, 
Clickhaler, Easyhaler, Diskhaler, Discus, Twisthaler, Spiros, and others. 
DPIs are as effective as the older devices, and generally have a better taste 
and are easier to manage. They may differ among themselves, however, in 
their ability to deliver drugs into the airways. In one study, for example, the 
Turtx)haler was easier to use than the Diskhaler and so achieved better 
delivery. The Discus is another effective DPI; it has a dose counter and 
protects against exhalation effects. More research is needed. 
Humidity or extreme temperatures can effect their performance, so 
they should not be stored in humid places (e.g., bathroom cabinets) or 
locations subject to high temperatures (e.g., glove compartments during 
summer months). 
8.6.2 Nebulizers. A nebulizer is a device that administers the drug in a fine 
spray that the patient breathes in. They are mostly used in hospital settings 
or when the patient cannot use an inhaler. Nebulizers may be important for 
delivering newer agents used in asthma treatment. 
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8.7 Monitoring 
People who self-manage their asthma using daily monitoring of peak 
air flow and adjusting their medications as needed have fewer 
hospitalizations, fewer unplanned doctors visits, and, generally, a better 
quality of life than those who rely only on the occasional physician or 
emergency room visit to control symptoms. Physicians recommend that 
patients with even mild asthma monitor their own conditions. 
In general, monitoring involves the following steps: 
• A peak flow meter is the standard monitoring device for measuring 
peak expiratory flow rate (PEFR). 
• Patients with severe asthma should take PEFR readings two or three 
times a day. The overall goal should be to achieve less than a 20% 
(and ideally only 10%) variation in readings between evening and 
morning rates. For mild to moderate asthma, a single determination 
each morning usually suffices, but patients should check with their 
physicians. 
• It is important to use the meter at the same times each day and to 
stand or sit in the same position in order to keep an accurate record. 
• Patients should keep an ongoing record of their peak flow readings to 
help them detect worsening of their condition. 
• They should also record attacks, exposure to any allergens or 
triggers, and medications taken. 
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• After about two months, patients and physicians can use the data 
recorded for administering medications effectively and to recognize 
problems before they become serious. 
In general, many people fail to monitor their asthma. Experts believe 
that, ideally, portable monitors should be available to measure forced 
expiratory volume (FEV1), which is more accurate gauge of lung function, 
and the results should be electronically transmitted to the physician. 
9. WHAT ARE THE SPECIFIC DRUGS USED TO PREVENT 
ASTHMA ATTACKS AND REDUCE AIRWAY INFLAMMATION? 
9.1 Corticosteroids 
Corticosteroids, also called glucocorticoids or steroids, are powerful 
anti-inflammatory drugs. Steroids are not bronchodilators (that is, they do 
not relax the airways) and have little effect on symptoms. Instead, they work 
over time to reduce inflammation and prevent permanent injury in the lungs. 
Many studies have now shown that the use of inhaled corticosteroids in 
patients with moderate to severe asthma significantly reduce the rate of 
rehospitalizations and deaths from asthma. Nevertheless, they are still 
significantly underprescribed in the patients who need them most. 
9.1.1 Inhaled Corticosteroids. Inhalation of corticosteroids makes it 
possible to provide effective local anti-inflammatory activity in the lungs with 
minimal systemic effects. (Oral steroids have considerable side effects.) 
They are currently recommended as the primary therapy under the following 
circumstances: 
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• For any asthmatic condition more serious than occasional episodes 
of mild asthma. (Low-doses of inhaled steroids may even be safe and 
effective for some people with mild asthma, particularly those who 
find themselves using beta2-agonists daily.) 
• When treatment with bronchodilators is not effective. 
Examples of inhaled corticosteroids are the following: 
• The most recent generation of inhaled steroids include (in order of 
potency) fluticasone (Flovent), budesonide (Pulmicort), triamcinolone 
(Azmacort and others), and flunisolide (AeroBid). In general, the 
newer agents, are more powerful than the older generation of inhaled 
agents. Experts have some concern, then, that these potent agents, 
particularly fluticasone, may produce major side effects similar to oral 
agents. Studies are now suggesting, however, that the same benefits 
can be achieved with low doses of fluticasone as with high doses, 
thus reducing risks for serious side effects. (Of note, budesonide 
appears to be safe during pregnancy.) 
• The older corticosteroid inhalants are beclomethasone (Beclovent, 
Vanceril) and dexamethasone (Decadron Phosphate Respihaler and 
others). They are less powerful than the newer steroids when 
delivered with standard inhalers. New inhaler systems for, however, 
such as QVAR, which uses extra fine formulations of beclomethasone 
to allow deep delivery into the lungs may prove to be as effective as 
the newer, more potent steroids. 
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• Inhalers that combine both long-acting beta2-agonists and 
corticosteroids are now available. 
• Inhaled corticosteroids must be taken regularly. It may take a month 
to perceive their effects and up to a year to achieve full benefits. 
Some of these agents may have some immediate benefits; in one 
study, inhaled budesonide reduced inflammation in the airways within 
six hours. 
Optimal timing of the dose is important and may vary depending on 
the medication. Most of the newer inhaled steroids and even some older 
ones are now available as a single daily dose, which some patients may 
respond to. 
Side effects of inhaled steroids are the following: 
• The most common side effects are throat irritation, hoarseness, and 
dry mouth. These effects can be minimized or prevented by using a 
spacer device and rinsing the mouth after each treatment. 
• Rashes, wheezing, facial swelling (edema), fungal Infections (thrush) 
in the mouth and throat, and bruising are also possible but are not 
common with inhalators. 
Inhaled steroids are generally considered safe and effective and only 
rarely cause any of the more serious side effects reported with prolonged 
use of oral steroids. A 2001 study, however, reported a higher risk for 
cataracts in patients over age 40. (No higher risk was observed in younger 
people.) Others are reporting a higher risk for bone loss in patients who take 
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inhaled steroids regularly. (A number of bone-preserving medications are 
now available that might safely offset this effect.) There is also some 
concern that the more potent agents, particularly fluticasone, suppress the 
adrenal system (which secretes natural steroids) to a greater degree than 
other steroid inhalants. (This is a serious side effect of oral steroids.) Of 
note, during pregnancy, inhaled budesonide and beclomethasone are 
considered to be generally safe. 
9.1.2 Oral Corticosteroids. Oral agents are usually the last dmgs to be 
added to an asthma treatment program and the first to be removed. 
Common oral corticosteroids include prednisone, prednisolone, 
methylprednisolone, and hydrocortisone. They very effectively reduce 
inflammation but are generally used only after hospitalization for an acute 
attack, in some severe cases, they may be used as maintenance. 
• effects of prolonged use of oral steroids include cataracts, glaucoma, 
osteoporosis, diabetes, fluid retention, susceptibility to infections, 
weight gain, hypertension, capillary fragility, acne, excess hair 
growth, wasting of the muscles, menstrual in^egularities, irritability, 
insomnia, and psychosis. Osteoporosis is a common and particularly 
severe long-term side effect of prolonged steroid use. Medications 
that can prevent osteoporosis include calcium supplements, 
parathyroid hormone, bisphosophonates, or hormone replacement 
therapy in post-menopausal women. Vitamin C and E may help 
reduce the risk of cataracts. 
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Long-term use of oral steroid medications suppresses secretion of 
natural steroid hormones by the adrenal glands. After withdrawal from these 
drugs, this so-called adrenal suppression persists and it can take the body a 
while (sometimes up to a year) to regain its ability to produce natural 
steroids again. It should be noted that there have been a few cases of 
severe adrenal insufficiency that occurred when switching from oral to 
inhaled steroids, which, in rare cases, has resulted in death. 
No one should stop taking any steroids without consulting a physician 
first, and if steroids are withdrawn, regular follow-up monitoring is 
necessary. Patients should discuss with their physician measures for 
preventing adrenal insufficiency during withdrawal, particularly during 
stressful times, when the risk increases. 
9.2 Long-Acting Beta2-Agonists and Corticosteroid Combinations 
Long-acting beta2-agonists. Including salmeterol (Serevent) and 
formoterol (Foradil), are used for preventing an asthma attack (not for 
treating symptoms). The effects of one dose of a long-acting beta2 agonist 
last for about 12 hours, so they are particularly effective during the night. 
These agents also may be used for prevention of exercise-induced asthma 
in people and to protect against aspirin-induced asthma. 
As with short-acting beta2-agonists, the long-acting forms have no 
effect on inflammation, and they should not be used alone on any regular on 
basis. Evidence suggests that such use may reduce the effectiveness of the 
short-acting beta2 agonists, which are the mainstays for treating acute 
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attacks. In patients with moderate to severe asthma, the long-acting beta2 
agonists are best used in combination with anti-inflammatory drugs. Adding 
these agents to a steroid regimen, in fact, may help prevent the need for 
higher doses of steroids. These inhalers appear to be safe and possibly 
more effective than either agent used alone for patients who do not respond 
well to other agents. 
Warning on Salmeterol. Both salmeterol and formoterol are beneficial 
and improve the quality of life. Formoterol has a much faster action than 
salmeterol and may achieve better control of nighttime asthma. Fonnoterol, 
in fact, works almost as fast as the short-acting albuterol and is sometimes 
used to treat asthma symptoms. Salmeterol, however, requires up to 20 
minutes to achieve effectiveness and should never be used for stopping an 
attack. There is a danger then of overdose if a patient is not aware of this 
delay and takes additional doses to achieve faster relief. (Overdose has 
been fatal in rare cases.) The risk appears to be highest in elderly patients 
with severe asthma. People using long-acting beta2 agonists should take 
the following precautions: 
• The medication should not be stored in locations that are easily 
accessible during acute attacks, such as by the bed or in a 
pocketbook. 
• Salmeterol should never be used for treatment of acute episodes; for 
this purpose, short-acting bronchodilators should be used. 
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(Formoterol has a faster action and may, in some cases, be used for 
treating symptoms, but patients should check with their physician.) 
Side Effects. Side effects of long-acting beta2 agonists are similar to 
the short-acting agents. 
9.3 Cromolyn and Similar Drugs 
Cromolyn sodium (Intal) serves as both an anti-inflammatory drug 
and has antihistamine properties that block asthma triggers such as 
allergens, cold, or exercise. Nedocromil (Tilade) is similar to cromolyn. A 
cromolyn nasal spray called Nasalcrom has been approved for over-the-
counter purchase, but only to relieve nasal congestion caused by allergies. 
Asthmatic patients should not use it for self-medication without the advice of 
a physician. 
Candidates. Cromolyn is often used in children with allergic asthma, 
but it has also been an important treatment for exercise-induced asthma 
(EIA) in all age groups, for pregnant women, and possibly for preventing 
allergic asthma in adults as well as children. Both cromolyn and nedocromil 
appear to be useful for patients with aspirin-induced asthma. These agents 
do not effectively treat asthma once an attack is underway. They also have 
very little long-term benefits on lung function compared to inhaled 
corticosteroids. 
Side Effects. Side effects of cromolyn include nasal congestion, 
coughing, sneezing, wheezing, nausea, nosebleeds, and dry throat. 
Nedocromil has an unpleasant taste and some people have complained of 
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nausea, headache, and spasms in the airways, but no serious side effects 
have been reported. 
9.4 Leukotriene-Antagonists 
Leukotriene-antagonists are oral medications that block leukotrienes, 
powerful immune system factors that, in excess, produce a battery of 
damaging chemicals that can cause inflammation and spasms in the ainways 
of people with asthma. As with other anti-inflammatory agents, leukotrienes 
are used for prevention and not for treating acute asthma attacks. 
The leukotriene-antagonists include zafirlukast (Accolate), 
montelukast (Singulair), zileuton (Ziflo), and pranlukast (Ultair, Onon). 
These agents are proving to be effective for long-term prevention of asthma, 
and possibly for exercise-induced asthma or aspirin-induced asthma. They 
may also reduce the severity of allergy symptoms, regardless of whether or 
not asthma is also present. 
Many studies to date, however, are not finding any advantages 
compared to the more potent inhaled corticosteroids. Their anti-
inflammatory actions are different from those of steroids, and a combination 
of the two agents is proving to be particularly effective, although it is not yet 
clear when such combinations would be useful. 
Side Effects and Complications. Gastrointestinal distress is the most 
common side effect of leukotriene-antagonists. Very few other side effects 
have been reported. In general, these agents appear to be safe and well 
tolerated. 
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Of some concern are reports of Churg-Strauss syndrome in a few people 
taking zafirlukast or montelukast. Chiurg-Strauss syndrome is very rare, but 
it causes blood vessel inflammation in the lungs and can be life threatening. 
Oral steroids quickly resolve the problem. In fact, usually the syndrome has 
occurred in patients v^^o were tapering off steroids and changing over to the 
leukotrienes-antagonists. Some experts believe that, in such cases, the 
steroids may simply have masked the presence of the disorder, which then 
developed when the steroid drugs were withdrawn. Symptoms include 
severe sinusitis, flu-like symptoms, rash, and numbness in the hands and 
feet. 
Other concerns are indications of liver injury in patients taking 
zileuton and zafirlukast when taken at higher than standard doses. No 
adverse effects on the liver have been reported to date with montelukast. 
10. WHAT ARE WAYS TO MANAGE ASTHMA AND REDUCE 
THE ALLERGIC RESPONSE? 
About 50% of adults with asthma exhibit allergic responses. 
Avoidance or control of the triggers that lead to asthma attacks is as much a 
priority as treatment of the disease. An asthma attack can be induced or 
aggravated by direct irritants to the lungs. Important irritants or allergens 
include the following: 
• Dust mites, specifically mite feces, which are coated with enzymes 
that contain a powerful allergen. These are the primary allergens in 
the home. (In one study, allergies to dust mites did not appear to 
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have any affect on hospitalization, although they are capable of 
triggering asthma attacks.) 
• Animal dander. 
• Pollen. 
• Molds. 
• Fungi. 
• Cockroaches. Cockroaches are major asthma triggers and may 
reduce lung function even in people without a history of asthma. 
Of some concern are studies reporting no change in asthmatic 
symptoms after controlling cat or dust mite allergens. More research is 
needed to identify the reasons for this. 
10.1 Controlling Pets 
Patients who already have pets and are not allergic to them probably 
have a low risk for developing allergies. If pets trigger asthma, however, 
they should be kept outside. If this isn't possible, they should at least be 
confined to carpet-free areas outside the bedroom. Cats harbor significant 
allergens, v^ rtiich can even be carried on clothing; dogs usually present 
fewer problems. Washing animals once a week can reduce allergens. Dry 
shampoos, such as Allerpet, are now available for both cats and dogs that 
remove allergens from skin and fur and are easier to administer than wet 
shampoos. 
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10.2 Indoor Protection 
Removing Allergens from the Air and Carpets. Air cleaners, filters 
for air conditioners, and vacuum cleaners with HEPA filters can help remove 
particles and small allergens found indoors. Neither vacuuming nor the use 
of anti-mite carpet shampoo is effective in removing mites. In fact, 
vacuuming stirs up both mites and cat allergens. 
Carpets and rugs are major sources of allergens in any case and should be 
avoided if possible. HEPA vacuum cleaners appear to be effective in 
reducing levels of second-hand smoke and preventing cat allergens from 
being released into the air. Neither vacuuming nor the use of anti-mite 
carpet shampoo is effective in removing mites. In fact, vacuuming, even with 
a HEPA filter, stirs up both mites and cat allergens. 
House dust itself, hovt^ ever, can be a reservoir for pollen, so keeping 
a house dust-free is still helpful. A 2002 study reported that spray furniture 
polishing is very effective for reducing both dust and allergens. 
Bedding and Curtains. Using semipermeable coverings to fully 
encase mattresses and pillows is the most proven effective step in reducing 
dust mite levels. (Vinyl mattress covers limit airflow and may also 
exacerbate, or even cause, asthma in children. Synthetic pillows may pose 
a significantly higher risk for severe asthma attacks in children than feather 
or no pillows.) Curtains should be replaced with shades or blinds and 
bedding washed using the highest temperature setting. 
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Reducing Humidity in the House. Although warm, moist air from 
vaporizers can greatly ease and moderate asthma attacks, living in a damp 
house is counter productive. Dust mites thrive in humidity and damp houses 
increase the risk for mold. On-going humidifiers, then, can be 
counterproductive. If they are used, humidity levels should not exceed 40% 
and they should be cleaned daily with a vinegar solution. 
Gas Stoves and Kerosene. People with asthma who cook should 
choose electric ovens rather than gas, which release nitrogen dioxide, a 
substance that can aggravate asthma symptoms. (Children do not appear to 
be affected by gas cooking.) Kerosene (used in space heaters and lamps) 
may also produce allergic reactions. 
Exterminating Cockroacttes and House Mice. Cockroaches should 
be eliminated by professional exterminators, although a study reported that 
ridding a home of cockroaches and cleaning the house using standard 
housecleaning techniques failed to eliminate the cockroach allergens 
themselves. Mice should be eliminated, and attempts should be made to 
remove all dust, which might contain mouse urine and dander. 
Avoiding Smoldng and Cigarette Smoke. Cigarette smoke can 
accelerate the decline in lung function related to asthma. Even exposure to 
secondhand smoke can double the risk of asthma-related emergency room 
visits. In one study, it was the most frequently cited trigger of asthma 
symptoms. Everyone should quit smoking and encourage others around 
them to quit. 
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10.3 Outdoor Protection 
Avoiding Outdoor Allergens. The following are some 
recommendations for avoiding allergens outside: 
• Camping and hiking trips should not be scheduled during times of 
high pollen count. Patients should avoid strenuous activity when 
ozone levels are highest, which usually occur in early afternoon, 
particularly on hot hazy summer days. Levels are lowest in early 
morning and at dusk. 
• Asthma attacks are often higher during thunderstorms. It is not clear 
why. Some evidence points to a build-up of ozone that accompanies 
such stomns. One study suggested that changing airflow patterns 
bring a sudden downdraft of air containing concentrations of pollens, 
small particles and allergens. 
• Patients who are allergic to mold should avoid bams, hay, raking 
leaves, and mowing grass. Exposure to automobile fumes may 
worsen asthma. Fungi in car air conditioners can also be a problem. 
• Exposure to Air Pollution. A number of studies have linked air 
pollution to asthma. An important 2000 study found a strong 
association between higher mortality rates from heart and lung 
diseases and high levels of specific pollutants (ozone, carbon 
monoxide, sulfur dioxide, and nitrogen dioxide). Some experts point 
out that asthma rates in North America have increased over recent 
years while the prevalence of many common air pollutants have 
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declined. So pollution is unlikely to be a primary cause of asthma. 
Nevertheless, evidence strongly suggests that air pollution can 
worsen existing asthma and patients should take precautions if they 
are exposed to polluted air. 
10.4 Allergy Shots 
Allergy shots (immunotherapy) are proving to be highly effective in 
reducing allergic asthma symptoms in both adults and children. 
Immunotherapy can also prevent the development of new allergies, the 
worsening of allergic symptoms, and the onset of asthma in susceptible 
people. 
10.5 Preventing and Treating Respiratory Infections 
People with asthma should try to minimize their risk for respiratory 
tract infections. Washing hands is a very simple but effective preventive 
measure. 
There has been some question concerning influenza vaccinations because 
of some reports that vaccines may worsen asthma. Recent and major 
studies have been reporting, however, that the vaccination is safe for adults 
and children. It is also very important for patients to reduce their risk for 
respiratory diseases. Still, 90% of asthma patients remain unvaccinated. 
Asthma patients should ask their physicians about the flu vaccine 
and also whether they should receive the vaccination against pneumococcal 
pneumonia. 
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Zanamivir, a new drug used for treating influenza, is now considered 
safe for asthma patients 12 years of age or older. And, in one study, asthma 
patients treated with zanamivir experienced fewer flu symptoms and their 
lung function improved. 
10.6 Occupational Asthma and Reducing Risit 
A number of studies have estimated that between 2% and 26% of 
adult-asthma cases are related to work history. Some experts encourage 
physicians to suspect occupational factors in alt cases of adult-onset 
asthma. Although workers who have allergies, who smoke, or both are at 
higher risk than others, any worker exposed to occupational triggers may be 
at risk for asthma. 
Work-related asthma is one of two types: 
• Work-aggravated asthma, in which existing asthma symptoms are 
triggered by irritants at the workplace. 
• Occupational asthma, which is new-onset asthma strongly associated 
with conditions at work. 
Occupational asthma is further categorized as the following: 
• Nonlatent (symptoms occur right after exposure to an irritant, usually 
high concentrations of gas, fumes, dust, or chemicals). 
• Latent (symptoms develop after prolonged exposure to substances in 
the workplace). 
50 
Occupational Triggers. Over 250 agents have been identified as 
potential occupational triggers of asthma and the list is growing. A few of the 
chemicals and substances that are particularly problematic include: 
• Isocyanates used in the manufacture of polyurethane, paints, steel, 
and electronics. 
Trimellitic anhydrides (TMA) used in many plastics and epoxies. 
Western red cedar, oak, redwood, and mahogany. 
Metal salts (platinum, nickel, and chrome) and metal working fluids. 
Vegetable dusts (soybeans, grains, flour, cotton, and gums). 
Biologic agents (Bacillus subtilis, pancreatic enzymes). 
Xylanase used in the baking industry. 
Pharmaceutical agents (penicillin, phenylglycine acid chloride). 
Glutaraldehyde used to sterilize medical equipment. 
Red dye made from the cochineal insect. 
Workers in these industries and others, including farmers, 
hairdressers, and those who work in the garment industries, are at risk for 
asthma. 
Preventing Occupational Asthma. In people whose asthma is caused 
by workplace conditions, improved ventilation or face masks may help. 
Sometimes, however, even low levels of chemical agents can trigger 
an asthma attack. In such cases, leaving the job is the only way to prevent 
the condition from getting worse. Because such a step can be emotionally 
and financially threatening, workers should be sure that occupational 
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substances are the cause of the asthma by having a complete check-up by 
a lung specialist. 
If the diagnosis of occupational asthma is certain, patients should obtain 
advice on available compensation plans for disability. The effects of 
workplace asthma can be permanent. However, in one study, 70% of people 
with asthma experienced significant improvement in symptoms after leaving 
the job. 
10.7 Dietary Factors 
10.7.1 Weight Loss. People who are both asthmatic and ovenweight may 
reduce asthma symptoms simply with weight loss. 
10.7.2 Antioxidant Foods and Supplements. Some evidence indicates 
that having low dietary intake of antioxidant nutrients (vitamins A, C, and E, 
selenium and other food chemicals) could increase the risk for lung 
damage. Taking supplements does not appear to have any effective. Such 
nutrients are best obtained from fresh, deep green and yellow-orange fruits 
and vegetables, which contain other chemicals that might be lung 
protective. In one study, people who consumed selenium-rich foods (fish, 
red meat, grains, eggs, chicken, liver, and garlic) had a lower risk for 
asthma. In the same study, eating apples was also associated with 
protection. (Apples contain important food chemicals called flavonoids.) 
10.7.3 Fisii Oil. Omega-3 fatty acids, found in cold water oily fish and in 
supplements (usually DHA-EPA) have anti-inflammatory effects and may be 
helpfui for asthma. 
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10.7.4 Role of Food Allergies. Although 67% of asthmatics believe their 
symptoms are aggravated by food allergies, studies indicate that this belief 
may be true in only 5% of cases. The primary suspects are monosodium 
glutamate, or MSG (found in some canned soups, cheese, and certain 
vegetables), and sulfites (preservatives in wine and foods that include 
processed frozen potatoes and tuna). Contrary to vvhat many believe, dairy 
products do not appear to exacerbate asthma symptoms in people who are 
not already allergic to them. 
10.8 Exercise 
It should be noted that asthma is no reason to avoid exercise. 
Historically, about 10% of US athletes who participated in the Olympics 
have been asthmatic. Some studies are indicating that long-term exercise 
may even help control asthma and reduce hospitalization. Patients should 
consult their physicians before embarking on any exercise program, 
however. It should be strongly noted that uncontrolled asthma can be 
dangerous and, in rare cases, fatal for athletes, even some with mild 
asthma. Use of the inhaler is extremely important. 
People who enjoy running should probably choose an indoor track to 
avoid pollutants. Swimming is excellent for people with asthma. Yoga 
practice, which uses both stretching, breathing, and meditation techniques 
may have particular benefits. One study reported that two-thirds of patients 
who practiced yoga regularly were able to reduce or stop taking their 
asthma medications. 
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Exercise-induced asthma is a limited condition that has specific 
recommendations. 
10.9 Reducing Stress and Mood Disorders 
People with asthma have no higher rate of anxiety or depression than 
the general population. However, such emotions interact with the effects of 
asthma and its treatments in important ways: 
• Negative emotions can discourage compliance with medication and 
the ability to cope. 
• Poor control of asthma symptoms, in turn, Increases the risk for 
negative emotions. 
• Stress and depression have been associated with more severe 
symptoms and even an increased risk of fatal asthma attacks. 
On the other hand, a positive attitude and relaxation techniques may be 
very helpful in the long-temn management of asthma. 
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Conclusion: Asthma is a chronic inflammatory disorder of the airways 
characterized by reversible airflow obstruction causing cough, wheeze, 
chest tightness and shortness of breath. Inflammation of the bronchial wall 
involving eosinophils, mast cells and lymphocytes, together with the 
cytokine and inflammatory products of these cells, induce hyper-
responsiveness of the bronchi so that they narrows more reality in response 
to a wide range of stimuli. Asthma may be of various cause, viral infections. 
Atmospheric pollution, cold air, emotion, genetic factors etc. Bronical 
Asthma is a common disease: 15% of children report infected according to 
WHO (World Health Organization) reports. A diagnosis of Asthma is made 
on the basis of compatible clinical demonstration of variable. 
^( Ace. No ."; • « 
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BIBLIOMETRIC 
INTRODUCTION 
This is an age of research and expedition in every field of knowledge. 
Consequent increase in the production of information is best reflected in 
the literature of every discipline. The case of literature that supports 
research activities is mainly constituted of journals. Growth in the number of 
specialized disciplines, increasing number of journals published in each of 
them and the escalating cost of this inevitable and ubiquitous medium of 
communication present constraints to the librarians in judiciously chalking 
out effective acquisition programmes for journals and related information. 
Realizing this factor, no single library can afford to acquire every 
document. Hence, limited and selected procurement of journals seem to be 
one of the practical remedies. There is high time to draw up theory methods 
and forms of their recognition standardized the system of main concepts in 
the bibliographical organization and services on the basis of statistics. 
To meet these challenges, recent development in the library and 
information science may be looked into. Developments in library operation 
are being manifested through the so-called Bibliometrics i.e. statistical 
analysis. It is the study conducted to identify the pattern of publications, 
authorship and citation used for a subject etc. over a period of time and 
there by offering Insight into dynamics of the area under a particular study. 
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So 'Bibliometric' is a relatively new branch of information science, 
which lies between the border areas of social and physical science. It is a 
quantitative study of various aspects of literature on a topic and is used to 
identify the pattern of publication, authorship, citation and / or secondary 
journal coverage, with the objective of getting an insight into the dynamics of 
the growth of knowledge in the areas under consideration. This all 
consequently leads to the better organization of information resource, which 
is essential for its most effective and efficient used. 
Bibliometric today has attained sophistication and complexity having 
national, international and interdisciplinary character. It has clearly become 
established as a sub discipline with its applications in the history and 
sociology of knowledge. Communication and Information science. 
1. BIBLIOMETRICS: Its Origin and History 
The first recorded study on Bibliometrics was done In 1917 by Cole 
and Eale's the study on "The History of Comparative Anatomy part-l". "A 
statistical Analysis", for the first time the expression "Statistical Analysis' 
has been used in the literature. The second study done by Hulmes in 1923 
used the expression 'Statistical Bibliography". The third study was the 
pioneering work of Gross and Gross reported in 1927 the used the method 
of counting and analysis of the citations appended to article in the journal of 
"American Chemical Society" and produced a list of journals of importance 
in chemical education. After gross and gross, the term statistical 
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Bibliography was used by Henkle in 1938 in his article, "The periodical 
literature of Biochemistry", 1948/49, by Raising in 1962 in their work. 
In 1968 Pritchard analyzed the term 'Statistical Bibliography' and 
found it to be confusing with 'Statistics' and Bibliography on statistics'. 
Therefore, he coined another term i.e. called "Bibliometrics". 
2. Definition of different Analogous term 
Bibliometrics is just one of the many sciences whose name ends with 
metrics. Many scientists have used the term under different names, but the 
concepts were more or less same. Same well established sub-disciplines 
like, Scientometrics, Informatrics, Econometrics etc. 
2.1 Librametrics 
The temn "Librametry" historically appeared first in 1948. It was 
suggested by Indian library scientist S.R. Rangananthan. Under this 
temi he suggested using of mathematical and statistical method for 
analysing library activities and library resources. But this tenn did not 
take its place in library science and was forgotten for many years. Later 
it was called librametrics. 
2.2 Scientometrics 
In 1969, the term 'Scientometrics' was suggested by two Russians 
named Nalimov and Z. Mulchinko in their book "Scientometrics: The 
investigation of science as development of information process". 
According to them Scientometrics is a complex quatitative methods, 
which are used to investigate the processes of science. 
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2.3 Informatrics 
The FID'S term 'Informetrics' wa suggested by German scientists A 
Blakert and S.Z. Zygel In 1982 as a newly formed branch of science, 
using mathematical level and practical information activities. 
2.4 Webmetrics or Cybermetrics 
Recently a new growth area in bibliometric has been in the emerging 
field of Webmetric or Cybermatirc as it is in often called. Webmetrics 
can be defined as using of bibliometric techniques in order to study the 
relationship of different site on World Wide Web such techniques may 
be also be used to map out (called "Scientific mapping" in the traditional 
bibliometric research area of the web) some other well established sub-
discipline like Econometric, Psychometrics, Sociometrics and 
Biometrics. 
3. BIBLIOMETRICS: ITS MEANING AND DEFINITION 
Etymologically Bibliometrics is composed of two distinct words i.e. biblio 
and metrikas. The prefix Biblio is a Greek word meaning books and Metrikas 
means measurement. So Bibliometrics is the Science of measurement 
pertaining to books or documents. 
It is the term 'Bibliometrics' implies the use of quantitative or 
statistical methods to study the behaviour of information. 
Ther are numbr of definitions of Bibliometrics given by the different 
researcher such as Hulme, Raising, Farithorne, Schrader, Sengupta, 
and others. However, a more elaborate concept of Bibliometrics has 
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recently been expounded by Egghe, who define it has the development 
and application of mathematical (including statistical and optimizational) 
models and techniques to all aspects of communication (including 
libraries, documentation and information centres science policy). 
Diverse interpretation of the terms have been put forward by many 
authors over the years. 
> According to Wyandham E. Hulme (1923) 
The purpose of Statistical Bibliography is to shed light on the process 
of vwitten communication and of the nature and course of 
development of a discipline by means of counting and analysing the 
various facets of written communication. 
> According to Miks, L. Raising (1962) 
The assembling and interpretation of statistics relating to books and 
periodicals use of books and journals and to ascertain in many local 
situations the general use of books and journals. 
> According to Pritchard (1968) 
Application of mathematical methods to books and other media of 
communication. 
> According to R.A. Fairthorns (1969) 
Quantitative treatment of the properties of record discourse and 
behaviour appertaining to it". 
> According to D.T. Hawkins (1977) 
Quatitative analysis of the bibliographical features of a body of literature. 
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> According to W.G. Potter 
Bibliometrics is tine study and measurement of the publication patterns of 
all forms of written communication and their authorship. 
> According to Alwin, M. Schrader 
Bibliometrics is the scientific study of recorded discourse. 
> According to R.N. Broadus 
Bibliometrics is the qualitative study of physical published units of 
bibliographic units of Surrogates either. 
> According to I.N. Sengupta 
Organization, classification and quantitative evolution of publication 
patterns of all macro and micro communications along with their 
authorship by mathematical and statistical calculus. 
Expressed simply, Bibliometrics is the study that uses statistical and 
mathematical method to analyze. Th literature of a discipline as it is 
patterned in its bibliographies. 
4. BIBLIOMETRICS: ITS SCOPE 
The scope of Bibliometrics include the study of relationship within a 
literature or describing a literature, typically these description focus on 
consistent patterns involving authors, monograph journals, subject, 
language and forms. Ronald Stevens has considered Bibliometrics as a 
quantitative science and divided its scope into two basic categories. 
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4.1 Descriptive Bibliometrics Productive to Count, which includes 
(i) Geographic 
(ii) Time period, and 
(ill) Discipline 
4.1 Evaluative Bibliometrics or Literature use count, which includes: 
(i) Reference count 
(ii) Citation count 
Stevens further adds that desaiptive Bibliometrics include the "study of 
the number of Publication in a given field or productivity of literature in the 
field, for the purpose of comparing the amounts of research in different 
countries, the amount produced in different subdivisions of the field. The 
kind of study is made by a count of the papers, books and other writings in 
the field or often by count of thesis writings which have been abstracted in 
specialized abstracting journals. The other i.e. evaluative Bibliometrics 
include the study of the literature used by research workers in a given field. 
Such a study is often made by counting the references cited by a large 
number of research worker in their papers". 
5. BIBLIOMETRIC: ITS PURPOSE 
Hulmes, the pioneer of the 'statistical bibliography' clearly stated 
the purpose of Bibliometrics is to shed light on the processes of written 
communication and of the nature and course of development of a 
discipline (in so far as this displayed through written communication), by 
means of counting and analyzing the various facets of written 
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communication .... According to Schrader "the objective of Bibliometrics 
is a scientific study of produce ideas that is theory about recorded 
discourse and its important properties". 
According to Dr. S.N. Singh "The purpose of Bibliometrics is to 
provide quatitative analysis of the phenomenon growing with 
documents, their organization, use and services in library and 
information centers and systems. It offers to the information worker a 
type of statistics and attributes of literature and that of communication 
media". The main purpose of Bibliometric study is: 
a. To find major form of literature. 
b. To prepare a ranked list of journals. 
c. To make a comparison between ranked journals. 
d. To identify the country with greatest literary output. 
e. To find out the chronological scattering of all cited literature. 
f. To ascertain the amount of utilization of language. 
So Bibliometric studies are generally based on quantitative 
measurements without any qualitative evaluation. They are therefore 
considered only as partial indicators of scientific progress so, its 
purpose basically is to provide information about the structure of 
knowledge and how it is communicated. 
6. BIBLIOMETRICS: ITS SIGNIFICANCE IN THE RESEARCH 
At present it is an established technique covering wide area of 
knowledge, which provides for a more practical task. Day by day, it is 
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attaining sophistication and complexity, having national, international 
and interdisciplinary and complexity, having national, international and 
inter-disciplinary character. It has established itself as a viable and 
distinctive research technique of studying science of science based on 
bibliographic data. As a matter of fact, its backbone lies in its sound 
theoretical foundation most efficiently and effectively laid by some 
pioneers lime Gross, Lotka, Bradford, Zipf, Cole Brother, Pritchard, 
Garfield, Huleme, Fairthorne and many others who are all not basically 
librarians, but belong to different branches of knowledge. 
The techniques evolved by these pioneers ar capable of throwing 
light on various complicated problems faced by many while handling 
information to quantify the process of written distinctive measurement of 
human knowledge. Data analysis both of citations and of volume of 
publications year can be useful in planning retrospective bibliographies. 
Bibliometrics also provides information about the structure of 
knowledge, its classification studies give information about the subject, 
language and country relationship, which is based on literary warrant 
Bibliometrics is very useful in any field of research or in any discipline or 
individuals, to improve some part of library or information service. 
7. BIBLIOMETRICS: ITS LAWS 
As Bibliometric law has evolved, a series of law have developed 
within an academic discipline these laws help researchers to study some 
common activity examples of activities could be the use of library 
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materials, author productivity or the dispersal of articles on a particular 
subject. Some of the more well known laws are Bradformd's law, Lotka's 
law and Zipf s law. These are fundamental laws are as follows: 
7.1 Lotka's inverse square Law 
In 1926, Alfred J. Lotka statistician in an Insurance Company proposed 
his Inverse Square Law correlating contributors of scientific papers to 
their number of contributions. He claims that a large proportion of the 
literature is produced by a small number of authors and it is distributed 
so as the number of people producing n papers or articles is 
approximately proportional to 1/n2. 
Author a 1/n^  
Where n is the number of contributions or articles. 
For this, he analyzed the decennial index of 'Chemical Abstracts' 
from 1907-1916. He collected 6891 names of the authors contributing 1, 
2, 3 etc. entries in literature. 
On the basis of this data, Lotka deduced a general equation, for 
the relation between the frequency 'y' of persons making Y contributions 
as follows: 
Xny = constant 
If n = 2 then, the result as follows: 
"In the case examined it is found that the number of persons 
making 2 contributions is about one-fourth of those making one 
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contributions, the number making 'n' contributions is about 1/n2 of those 
making one and the proportion of all contributions is about 60%. 
In other words, for every 100 authors contributing one article, 25 will 
contribute two articles, about 11 will contribute, 3 articles and 6 will 
contribute 4 articles and so on. The observed figure for single article 
authors were 57.09% for chemical abstract data (61891 contribution) 
and 59.2 % for physical data (1,325 contributor). Through, the law was 
based on the study of Chemistry and Physics literature later it has 
generated much interest and attracted the attention of researchers and it 
has been applied and tested in many other fields. 
No. of Authors 
100 
25 
11 
6 
4 
No. of articles 
1 
2 
3 
4 
5 
7.2 Zipf s law of word occurrence (1933) 
This law ws given by Zipfs in 1933. Zipfs developed and extended 
an empirical law, as observed by Estoup governing a relation between 
the rank of a word and the frequency and the frequency of its 
appearance in a long text. 
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If V is the rank of a word and 'f is its frequency, then mathematically 
Zipf s law can be stated as follows: 
ra1/f =rf = c 
Where 'c' is a constant 
This law states that "in a long textual matter if words are arranged 
in their decreasing order of frequency, then the rank of any given word 
of the text will be inversely proportional to the frequency of the 
occurrence of the word". 
He found that by multiplying the numerical value of each rank ® 
by its corresponding frequency (f) be obtained a product © that is 
constant throughout its text e.g. 
Rank (r) 
1 
2 
3 
Frequency (f) 
600 
301 
198 
Product (if) = c 
600 
602 
594 
The above table how distribution of words, almost inversely proportional 
to the frequency of occurrence of the word. 
7.3 Bradford's Law of Scatering 
Samuel Clement Bradford, keeper of Science Museum in London, 
gave a Law of Scattering in 1948. This law is related to scattering of 
journals. In this law the scattering tern is used Scattering of journals 
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means the articles devoted to a particular subject are found in other 
journals (which are related subject to that particular subject). 
Brad ford Law is perhaps the best known of all the Bibliometrics 
concepts. His law describes how the literature on a subject is distributed 
in journals. He divided the articles found on subject into three equal 
zones, \Nh\dr\ increase by a multiple of about five. If periodicals are listed 
in decreasing productivity i.e. the journals that yield the most relevant 
articles coming first and the most unproductive last then the journals will 
be grouped into a number of zones each producing a similar number of 
relevant article. However, the number of journals in each zone will be 
increasing very rapidly and show a geometric progression. The 
relationship between the zones is to be given by following equation. 
1 : n : n^  
where n = number of journals 
Bradford also plotted graphs of the cumulative number of source item R 
(n) versus the logarithm values of the cumulative number of journals (log 
n). Such a graph, is sometimes called as Bradford's Bibliograph. 
Logn 
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There graph being as a rising curve, AP1, and then continues as a 
straight line. The rising part of the graph represents the nucleus of highly 
productive journals. The points P1, P2, and P3 on the bibliograph are the 
boundaries of three equiproductive zones is which the same number of 
articles as the nucleus derived from an increasingly larger number of 
journals. 
8. OTHER LAWS 
The other important laws that need to be mentioned there are : 
8.1 Price's square root law of scientific productivity 
This law was given by Derek De Sella Price in 1963. This law states 
that "half of the scientific papers are contributed by the square root of 
the total number of scientific authors". 
8.2 Garfield's Law of Concentration 
This law was enunciated by Eugene Garfield in 1971. This law states 
that "a basic concentration of journals is the common core of nucleus of 
all fields". 
8.3 Sengupta's Law of Bibliometrics 
This law has been put forward by Sengupta, in 1973 v4iich is also 
known as off setting weightage formula for re-ranking periodicals to 
avoid discrimination against new journals which necessarily have 
citation credits. This is basically an extension of the Bradford Law. 
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It states that "during phases of rapid growth of knowledge in a scientific 
discipline, articles of interest to that discipline appear in increasing number 
of periodicals from that field". 
Mathematically this law stands in the following form: 
F(x+y) = a + b log (x + y) 
Where f (x +y) is the communicative number of reference as contained 
in the first (x + y) most productive journals, x indicate number of journals in 
the same discipline and y stands for number of journals of unrelated 
disciplines (y>x) and 'a' and 'b' are two constant. 
9. BIBLIOMETRICS: ITS APPLICATIONS 
The technique of Bibliometrics have extensive applications equally in 
sociological studies of science, information management, librarianship, 
history of science including science policy, study of Science and Scientists 
and also in different branches or Social Science. 
Some of the areas where Bibliometrics techniques can be used are: 
> To identify research trends and growth of knowledge. 
> To estimate comprehensiveness of secondary periodicals. 
> To identify authorship and its trends in documents on various 
subjects. 
> To measure the usefulness of adhoc and retrospective SDI services. 
> To forecast past, present and future publishing trends. 
> To develop experimental models correlating existing ones. 
> To identify core periodicals in different disciplines. 
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> To formulate an accurate need-based acquisition policy within the 
limited budgetary provision. 
> To adopt an accurate weeding and staking policy. 
> To initiate effective multi-level network system. 
> To study obsolescence and dispersion of scientific literature 
(clustering and coupling of scientific papers). 
> To predict productivity of publishers, individual authors, 
organizations, country of that of an entire discipleine. 
> To design automatic language processing for auto-indexing, and 
abstracting and auto-classification; and 
> To development norms for standardiaation 
Most of the Librametry/lnformetic studies in the library and information 
field are concerned with the different types of uses and degrees to which 
user needs are satisfied. The studies are, however, becoming more 
analytical than descriptive. These studies may be ground as: 
> To make a careful and intensive study of the library situation (in the late 
40's) 
> To measure the adequacy of library collection for present and 
possible future library programmes (in the late 50's and in 60's). 
> To discover mathematical and statistical models for various 
phenomenon which we experience in library and information work 
and studies. 
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Methods used in empirical studies in the library and information field 
vary from one study to another. In several field studies questionnaires 
have been used. Casual visits, checklists, correspondence and 
interviews with user, and combinations of these with questionnaires, 
have also been used. The results are sometimes not compatible with 
each other or easy to compare because of the bias involved in the data 
collection methods. Nevertheless, the trends in informetrics in toward 
discovery of theory and/or generalized mathematical model of the 
library/information use phenomenon. Hopefully, these studies will help in 
achieving better services to library and information users and efficiency 
in information system and services management envisioned in 
Ranganathan's Five Law of Library Science. 
LIMITATIONS IN APPLICATION 
Though most of the studies tend to support the Bradford 
distribution some other researchers could not get the satisfactory 
results. Gross found that the scattering of research papers among 
physics journal deviated from that predicted by Bradford Law. Out of 50 
bibliographies studies by Chonez, only six followed the law, he calls the 
law pseudo-scientific. 
In the case of Lotka's Law it was found to fit in most cases. 
However, the value of indexing was found to vary different groups of 
scientists. 
Another problem with Lotka's Law is that it totally ignores the potential 
authors who have produced any publication so far. 
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CONCLUSION 
Bibliometric analysis, has now become a well-established part of 
information research, and quantitative approach to the description of 
documents and examination of services is gaining ground both in 
research and practice. It offers to the librarian, the students, the 
teachers, the sociologist of knowledge, and the publisher, a type of static 
not hitherto considered, which can complement further more traditional 
approaches to the study of bibliography and communication. As the 
definition suggests, Bibliometrics can be applies to any subject areas 
and to most of the problems, concerned with the written communication. 
Bibliometrics techniques have been gaining recognition and importance 
especially during the past two decades. The results of such studies are 
increasingly being applied to manage the library and information science 
resources and services more effectively. The studies of subject literature 
and their characteristics have also been found useful and helpful in 
managing the research and development activities in those subject 
specialists. 
Application of Bibliometrics technique is found in selecting most 
important journals in a given field of knowledge. The exponential growth 
of literature and rapid development of libraries generated several 
evolutionary studies about effectiveness and efficiency of information 
services. These studies led to the identification and application of 
appropriate quantitative measuring technique know as bibliographical 
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control, as it is not possible to start efficient service without analysing 
the size and character of literature. 
So expressed simply 'Bibliometrics' is the statistical or 
quantitative description of a literature, a group of related documents that 
furnishers possible methods by which significant features of a literature 
may be described and its working monitored. In fact Bibliometrics has 
grown out of the realization that literature is growing and changing at a 
rate with which no librarian or information worker equipped with 
traditional bibliographic methods and skill, could keep abreast. 
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OBJECTIVES AND METHODOLOGY OF THE STUDY 
The present study aims at identification and describing some of the 
characteristics of the literature published in the field of "Asthma" over the 
period of two years from 2001-2002 with a view to identifying place, year, 
language, subject areas, forms of documents, country of origin were the 
document is published. 
It is well known that knowledge is growing at very fast rate. The new 
researches and thirst for knowledge has led to the generation of new 
knowledge. It is necessary that new work and new findings should be 
highlighted among the research scholars and others who are interested in 
them. So Bibliometric study will help the Librarian in the selection of 
literature in the field of 'Asthma'. More precisely the main objective of the 
present study are: 
OBJECTIVE: 
(i) To know the most productive country in the field of 'Asthma', 
(ii) To know the eminent authors in the field of 'Asthma', 
(iii) To know the rate of collaborative research 
(iv) To know the language (s) in which the most of literature on the 
subject has been published 
(v) To know the most used form of documents, 
(vi) To find out the chronological distribution of items, 
(vii) To know the most productive journals in the field of 'Asthma'. 
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(viii) To identify the scattering of subjects. 
(ix) To check the validity of Lotka's and Bradford's Laws. 
HYPOTHESIS 
(i) There may be a significant difference regarding geographical 
scattering of article on 'Asthma', 
(ii) Influence of group research may be seen in authorship 'Asthma', 
(iii) English language in the field of Asthma is dominated, 
(iv) Journal articles may be the most used from of documents, 
(v) Chronological analysis of data may emerge as the reflection of 
acceleratory growth in the research out put of the literature year by 
year, 
(vi) Lotka's law will be valid in the present study, 
(vii) Bradford's law will stand valid in the present study. 
METHODOLOGY 
The exponential growth of literature and rapid development of 
libraries generated several evolutionary studies about the effectiveness and 
efficiency of information services. These studies led to the identification and 
application of appropriate qualitative measuring techniques known as 
Bibliometrics. 
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Research in any area calls for systematic methodologies. The 
methodology for conducting the bibliometric study has been 
diagrammatically represented below. 
Topic Selection 
I 
Selection of Source Document 
Collection of Data 
Preparation of Entries 
Analysis 
Country wise Ranking Language wise Form wise Year wise Ranking of Subject w 
Distribution of Author Distribution Distribution Distribution Periodical Distributi< 
(A) SELECTION OF TOPIC 
For the selection of the topic various sources have been consulted such 
as Chemical Abstract, Biological Abstract and Index Medicus. Finally the 
researcher selected "Asthma" from Index Medicus on his interest in Medical 
Science. 
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(B) SELECTION OF SOURCE DOCUMENT 
To undertake the Bibliometric study on the literature of 'Asthma' the 
Index Medlcus was found to be the most comprehensive and appropriate 
source of literature in the field of Medical science published by the National 
Library of Medical U.S.A., Washington D.C. 
(C) COLLECTION OF DATA 
The most important task was to select the document from which data has 
been drawn on the subject "Asthma" 3281 reference from the 2 volume of 
Index Medicus from 2001 to 2002 has been collected on 5" x 3" square 
inches catalogue card 
(D) PREPARATION OF ENTRIES 
By the help of Index Medlcus data was collected on catalogue cards 5" 
X 3". Each reference consisted of information about author name, title, 
source journal, date, place, fomi and text language were noted on card. In 
other words, a short bibliography was compiled on the cards. These were 
arranged and rearranged during analysis. 
(E)NEXT STEP AFTER PREPARATION OF ENTRIES 
Entries was to analyze the data was collected form the source document. 
The data collected on separate cards were arranged and rearranged in 
order to conduct the following studies: 
(i) GEOGRAPHICAL SCATTERING OF ITEMS 
This is done to determine the geographical scattering of items while 
studying the use pattern of research literature in the subjects under the 
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study. The information was collected from the Index Medicus of each item 
which clearly give the place of origin of each item. The entries were grouped 
on the basis of their country of origin. 
(ii) RANKING OF AUTHORS 
The researcher analyze the authors on the basis of their frequency of 
occurrence. This study has been conducted to know the eminent 
personalities in the field of 'Asthma'. Ranking of authors are done to identify 
the most productive contributions in the subject. For the purpose of ranking 
of authors, the researcher arranges them alphabetically, surname of each 
author is the basis for alphabetization. So all authors were retrieved 
arranged and tabulated in the order of decreasing frequency of their 
contribution. 
(ill) LANGUAGE-WISE DISTRIBUTION OF ITEMS 
In this study an attempt has been made to analyze the language 
wise distribution of items. Since the source of document Is of international 
level, and have comprehensive coverage, and article published in almost all 
languages of the world. So researcher analysed the items language-wise. In 
the Index itself the language of original text is given. While collecting the 
data, noted according to the language and then arranged according to their 
rank in order to know dominant language. 
(iv) FORM WISE DISTRIBUTION 
There are variety of forms of documents in which literature on 
'Asthma' are published. There are articles, editorial, news, letter etc. The 
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analysis has been done to know the major forms of documents used for 
producing new information in the subject under study. These have been 
tabulated to find out most uses source material. 
(V) CHRONOLOGICAL STUDY 
In this analysis time of origin of items were studied to know how many 
items belong to a particular time period on the basis of frequency of items 
belonging to a particular year. The data are analyzed and tabulated to find 
the most productive year of items. 
(V) RANKING OF PERIODICALS 
The main objective of this study is to identify the core periodical 
(journal) containing the research literature on 'Asthma'. To conduct this 
study, the items published in different periodicals were grouped together 
and counted. It is necessary to know the most productive periodicals in the 
subject 
(vi) SUBJECT WISE DISTRIBUTION 
This analysis has been done to know the scattering of literature of 
'Asthma' in other subject field. This analysis shows the interdisciplinary 
character of the subject field. The analysis has been done on the basis of 
field of periodicals publishing in the literature. The information about the 
subject field was obtained from Ulhch International Periodical Directory, 
(36"' ed). 
82 
APPLICATION OF BIBLIOMETRIC LAWS 
After doing ail tiie analysis the foremost and final job is to apply the 
laws of Bibliometrics. So the researcher tried to testify the laws of 
Bibliometrics by applying them on the collected data especially Bradford's 
and Lotka's Law in order to find out how much these laws are valid in the 
present study. 
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DATA ANALYSIS, INTERPRETATION 
AND 
REPRESENTATION 
Two volumes of Index Medicus for the year 2001-2002 were 
consulted for collecting required data on the topic 'Asthma'. In all 3281 
items on the subject were collected the data, was then analyzed as under: 
1. Ranking of Periodicals: Periodicals are the sources of current 
information. They play a vital role in scientific communication. In every 
subject there are certain core journals proceeding most of the literature. 
Identification of core journals in the subject under study will be useful from 
the point of view of scientist and librarians. 
The main aim of the present study is to identify the most important 
journals containing the most of the literature of research value in the field of 
'Asthma'. This information will go a long way in preparing a subscription list 
of periodicals. 
This information is useful for the information scientist as well as they 
know the names of core journals in their own field. 
Table 1 shows ranking of periodical distribution of items. In the 
collected data, all the 3281 references have been published 466 periodicals 
which have been ranked up to 42 positions. Table -1 shows that the first 
rank was occupied by the journal, titled 'Journal of Allergy and Clinical 
Immunology, which account frequency of 1831 i.e. 5.58% of total reference . 
85 
the next three positions are occupied by 'American Journal of Respiratory 
and critical care Medicine (5.22%), Chest (4.66%) and Annals of Allergy 
Asthma and Immunology (4.48%). 
Table - 1 Ranking of Periodicals 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
RANK 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
14 
15 
NAME OF PERIODICALS 
Journal of Allergy & clinical 
immimology 
American Journal of Respiratory & 
critical Medicine 
Chest 
Annals of Allergy, Asthma & 
Immunology 
Thorax 
European Respiratory Journal 
Clinical & Experimental Allergy 
Journal of Asthma 
Respiratory Medicine 
Allergy 
Zhongher a Jie He He Huxi Zashi 
Genetic Epdekmiology 
Archive of disease in childhood 
Cocharance data base system review 
Pediatric Pulmonology 
Jou mal of Association of 
Country 
U.S.A. 
U.S.A 
U.S.A 
U.S.A. 
U.K. 
Denmark 
U.K. 
U.S.A. 
U.K. 
Denmark 
China 
U.S.A. 
U.K. 
U.S.A 
U.S.A. 
India 
FREQUENCY 
183 
171 
153 
147 
130 
90 
89 
83 
75 
63 
57 
45 
44 
43 
43 
41 
%AGE 
5.58 
5.22 
4.66 
4.48 
3.96 
2.74 
2.71 
2.53 
2.28 
1.92 
1.73 
1.37 
1.34 
1.31 
1.31 
1.25 
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17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
16 
17 
18 
19 
19 
19 
19 
19 
19 
20 
20 
21 
22 
23 
24 
24 
25 
26 
27 
Physicians of India 
Current opinion of Allergy and 
clinical Immunology 
Morbidity and Mortality weekly 
Fortschr Medicine 
Environmental Health Perspectives 
Allergy and Asthma Proceeding 
British Medical Journal 
Clinical Allergy Immunol. 
Lancet 
Natural review of Immunology 
Nippon Rinsh: Japane Journal of 
clinical medicine 
Monaldi Archives for chest disease 
Terapeuticheskii Arkhiv 
Pediatrics 
Revista Alergia Mexico 
Journal of Immunology 
Archives of Pediatrics and 
Adolescent Medicine 
Current Allergy Asthma Respiratory 
Pneumologie 
Archivos De Boonconeumologia 
Archive de Pediatric 
U.S.A. 
Germany 
U.S.A. 
U.S.A. 
U.K. 
France 
U.K. 
U.K. 
Japan 
Italy 
Russia 
U.S.A 
Mexico 
U.S.A. 
U.S.A. 
U.S.A. 
Germany 
Spain 
Franc 
38 
32 
31 
30 
30 
30 
30 
30 
30 
28 
28 
27 
26 
23 
22 
22 
21 
17 
16 
1.16 
0.98 
0.94 
0.91 
0.91 
0.91 
0.91 
0.91 
0.91 
0.85 
0.85 
0.82 
0.79 
0.70 
0.67 
0.67 
0.64 
0.52 
0.48 
87 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
27 
27 
28 
28 
28 
29 
29 
29 
29 
30 
30 
30 
30 
30 
30 
31 
31 
31 
32 
32 
Current opinion in investigating 
drug 
New England Journal of Medicine 
Canadian Respiratory Journal 
Polski Merkuriu sz Lckarski 
Repiration 
Act a Paediatrics 
Pediatric Allergy and Immunology 
Pulmonary Pharmacology and 
Therapeutics 
Respirology 
American Family Physician. 
Arerugi 
Indian Pediatrics 
Journal of American Medical 
Association 
Journal of Pediatrics 
Occupational & Environmental 
Medicine 
Duodecim 
Immunology and cell biology 
Indian journal of pediatrics 
American journal of Medicine 
American journal of Public Health 
U.K. 
U.S.A. 
Canada 
Poland 
Switzerland 
Norway 
Denniaik 
Poland 
Australia 
U.S.A 
Japan 
India 
U.S.A. 
U.S.A. 
U.K. 
Finland 
Canada 
India 
U.S.A. 
U.S.A. 
16 
16 
15 
15 
15 
14 
14 
14 
14 
13 
13 
13 
13 
13 
13 
12 
12 
12 
11 
11 
0.48 
0.48 
0.45 
0.45 
0.45 
0.42 
0.42 
0.42 
0.42 
0.39 
0.39 
0.39 
0.39 
0.39 
0.39 
0.36 
0.36 
0.36 
0.33 
0.33 
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56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
32 
32 
32 
32 
33 
33 
33 
33 
33 
33 
34 
34 
35 
35 
35 
35 
Clinical reviews in - Allergy & 
Immunology 
Drugs 
Journal of Family practice 
Journal of investigational 
Allergology & Clinical 
Immunologhy 
American journal of Physiology 
Lung, cell and molecular physiology 
Controlled clinical trials 
Kilini cheskaia Meditisina 
Life science 
Quarterly journal of Medicine 
Polaski Archiwum Medycyny 
wewnetraznej 
Perdiatrics in review 
Asian pacific journal of Allergy & 
Immunology 
Archives of internal medicine 
British journal of general practice 
Indian journal of chest diseases & 
allied science 
International Archives of Allergy & 
immunology 
U.S.A. 
New Zealand 
U.S.A. 
Spain 
U.S.A. 
U.S.A. 
Russia 
U.K. 
U.K. 
Poland. 
U.S.A. 
Thailand 
U.S.A. 
U.K. 
India 
Switzerland 
11 
11 
11 
11 
10 
10 
10 
10 
10 
10 
9 
9 
8 
8 
8 
8 
0.33 
0.33 
0.33 
0.33 
0.30 
0.30 
0.30 
0.30 
0.30 
0.30 
0.30 
0.27 
0.27 
0.24 
0.24 
0.24 
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73 
74 
75 
76 
11 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
35 
35 
35 
35 
35 
35 
35 
35 
36 
36 
36 
36 
36 
36 
37 
37 
37 
37 
International journal of Immunology 
Internal Medicne 
Journal of applied physiology 
Mediators of inflammanation 
Mediators of inflammanation & 
Allergy 
Nihon Kokyuki Gakkaizasshe 
Respiratory Research 
Tidsskrift For Den Norske 
Laegefomening 
American journal of respiratory cell 
and Molecular Biology 
International journal of clinical 
practice 
Medical journal of Australia 
Revue Des Maladies Respiratoires 
Ryoikibetsu Shokogan Shirigu 
Yao Hscuch Pao (Acta 
Pharmacutake sinica) 
Bio-Drugs 
Chinese medical journal (Eng) 
Current opinian in Pulmonary 
Medicine 
European Journal of Epidemiology 
U.K. 
Japan 
U.S.A. 
U.K. 
U.S.A. 
Japan 
U.S.A. 
Norway 
U.S.A. 
U.S.A 
Australia 
France 
Japan 
China 
U.K. 
China 
U.S.A. 
Holland 
8 1 
8 
8 
8 
8 
8 
8 
8 
7 
7 
7 
7 
7 
7 
6 
6 
6 
6 
0.24 
0.24 
0.24 
0.24 
0.24 
0.24 
0.24 
0.24 
0.21 
0.21 
0.21 
0.21 
0.21 
0.21 
0.18 
0.18 
0.18 
0.18 
90 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
37 
37 
37 
37 
37 
37 
37 
37 
38 
38 
38 
38 
38 
38 
38 
38 
38 
European journal of pharmacology 
European Review for Medical and 
Pharmacological science 
Journal of consulting and clinical 
psychology 
Nederlands Tijdscnrift voor Geneer 
Kunde 
Nurse practioner 
Pediatric Annals 
Saudi Medical Journal 
Vestnik Rossis Koi Akadem Media 
Sinskikn Nauk 
Allergy clinical immimology 
Acta Paediaqtric Taiwan 
Allergologia ET Immunopathologia 
Amrican journal of Cell and Mol 
Biol 
American journal of Industrial 
Medicine 
Armals of Pharmacotherapy curie -
Sklodowska section D Medicine 
Bratislavske Lekarske Listy 
Clinical Pediatrics (Phila) 
Critical Therapeutics 
Holland 
Italy 
U.S.A. 
Holland 
U.S.A. 
France 
Saudi Arabia 
Russia 
U.S.A. 
Taiwan 
Spain 
U.S.A. 
U.S.A. 
Poland 
Russia 
U.S.A. 
U.S.A. 
6 
6 
6 
6 
6 
6 
6 
6 
5 
5 
5 
5 
5 
5 
5 
5 
5 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.18 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
91 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
38 
38 
38 
38 
38 
38 
38 
38 
38 
38 
38 
38 
38 
38 
39 
39 
39 
39 
39 
39 
39 
39 
Clinical care medicine 
Epidemiology 
European journal of pharmacology 
Journal of clinical Epidemiology 
Korean journal of Internal Medicine 
La kartidnigen 
Medicina clinica 
Nature 
Pediatrics drugs 
Pediatric pulmonology supplement 
Respiratory care 
Scandinavian J of Primary Health 
care 
Ugeskrist laeger 
Wiadomosci Lekarskie 
Academic Emergy Medicine 
Allergy Immunol (Allergic ET 
Immunologic) 
Allergologia ET immunopathologia 
Ambul Pediatrics 
American journal of pathology 
American journal of therapeutics 
British jou mal of Pharmacology 
Canadian Medical Physician 
U.S.A. 
U.S.A. 
Germany 
U.K. 
S.Korea 
Sweden 
Spain 
U.K. 
U.K. 
U.S.A. 
U.S.A 
Norway 
Demark 
Poland 
U.S.A. 
France 
Spain 
U.S.A. 
U.S.A. 
U.S.A. 
U.K. 
Canada 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
4 
4 
4 
4 
4 
4 
4 
4 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.15 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
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129 
130 
131 
132 
134 
135 
136 
137 
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139 
140 
141 
142 
143 
144 
145 
146 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
39 
Canadian Medical Association 
Journal 
Clinical Immunology and 
Immunopathology 
Contract Dermatitis 
Dtsch Med Wochonschr 
Family Practice 
Forensic science international 
International journal of 
Epidemiology 
Israel Medical 
Journal of clinical pharmacololgy 
Journal of pediatrics and child 
health 
Journal of American Geiatrics 
Society 
MCN; American journal of 
Maternal child Nursing 
Medicine and health 
Newzealand Medical journal 
Pediatric research 
Pharmacogenetics 
Pharmacology and therapeutics 
Pneumonolgia I Allergologia polska 
Canada 
U.S.A 
Denmark 
Germany 
U.K. 
Ireland 
U.K. 
Israel 
U.S.A. 
Australia 
U.S.A. 
U.S.A 
U.S.A 
Newzealand 
U.S.A. 
U.K. 
U.K. 
Poland 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
HI 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
39 
39 
39 
39 
39 
39 
39 
39 
39 
40 
40 
40 
40 
40 
40 
40 
40 
Presse Medicole 
Prold tuberlc 
Public health Nursing 
Revue Medicale De Liegi 
Scandinavian Journal of work. 
Environment & Health 
Swiss Medicine weekly 
Trends in Immunology 
Voprosy Kurortologii Fiziotera pii I 
Lechebnol Fizicheskoi Kutury 
Zhongguui Zhong xi yi Ji etk Zazhi 
AJR American journal of 
Roentgenology 
American jounal of Emergencey 
Medicine 
Allergy Immunology 
American journal of Human 
Genetics 
Annals of Epidemiology 
Annals of Esponoles De Pedia Tria 
Applicaion of occupational & 
Environmental hygiene 
Bulletin Experimental Biological 
Medicine 
France 
France 
U.SA 
Belgium 
Finland 
Switzerland 
U.K. 
Russia 
China 
U.S.A 
U.S.A. 
U.S.A. 
U.S.A. 
U.S.A. 
Spain 
U.K. 
U.S.A. 
4 
4 
4 
4 
4 
4 
4 
4 
4 
3 
3 
3 
3 
3 
3 
3 
3 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.12 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
94 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
Bio-medicine and pharmacologj' 
Current opinion in pharmacology 
Disease - A - month 
Emergency Medicine clinicws of 
North America 
Environmental research 
European Journal of Dermatology 
European journal of Emergency 
Medicine 
European journal of Human 
Genetics 
European Journal of Pediatrics 
Fascb Journal 
Genome Biol<^ 
Harefuah 
Himian genetics 
Indian journal of Medical science 
Int Archives of occupational & 
EnvircMimental Health 
Irish Medical Journal 
Journal of endocrinology and 
Metabolism 
Journal of Pediatric Nursing 
Laboratory Investigation 
France 
U.K. 
U.S.A 
U.S.A. 
U.S.A. 
Finland 
U.K. 
Switzerland 
Germany 
U.S.A 
U.S.A 
Israel 
Germany 
India 
Germany 
Ireland 
U.K. 
U.S.A. 
U.S.A. 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
0.09 1 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
95 
183 
184 
185 
186 
187 
189 
190 
40 
40 
40 
40 
40 
40 
40 
Likars ka SPRAVA 
Lung 
Medical care 
Medical science monitor 
Mount Sinai Journal of Medicine 
188 40 Nippon Naika Gakkai Zassahi (J of 
Japanese society of internal 
medicine 
Russia 
U.S.A. 
U.S.A. 
Portugal 
U.S.A. 
Japan 
Nippon Roven Igakkai zasshi 
(Japanese journal of Geriatrics) 
Nutrition 
Japan 
U.K. 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
0.09 
191 40 Occupation al medicine U.S.A. 0.09 
192 40 Phaemacoepidemiol Drug sufifering U.K. 0.09 
193 40 Prezegland Leakrski Poland 0.09 
194 
195 
40 
40 
Quality of life research Holland 
Recent progress in Medicina Italy 
0.09 
0.09 
1% 
197 
198 
199 
200 
40 
40 
40 
40 
40 
Revista clinica-Es-panola Spain 
Revista Da associacao Medica 
Brasileira 
Brazil 
Revista Pratic Portugal 
Salud Publica De Mexico 
Science 
Mexico 
U.S.A 
0.09 
0.09 
0.09 
0.09 
0.09 
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201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
40 
40 
40 
40 
40 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
Tunisie Medicale 
W. African Journal of Medicine 
Western Journal of Medicine 
Ya Kugaku zasshi (Journal of 
Phamiacutical Society of Japan) 
Zhumol Mikrobilogii Epidemiologii 
I Immunobiologii 
Acta Medica Okayma 
American journal of Health-system 
Pharmacy 
American journal of medicine 
Annals of Emergency Medicine 
Annals Universitatia Mariae curie 
Skloda 
Archives of Environmental Health 
Archivum immunologiae ET 
Therapiae Experimentalis 
British journal of Pharmacology 
British Medical Bulletin 
Canadian journal of public Health 
Cellular Immunology 
Clinical Evidence 
Clinical Pharmacokinetics 
Collegium Antropologicum 
Tunisia 
Nigeria 
U.S.A. 
Japan 
Russia 
Japan 
U.S.A 
U.S.A. 
France 
France 
U.S.A. 
Poland 
U.K. 
U.K. 
Canada 
U.S.A. 
U.S.A. 
Newzealand 
Yugoslavia 
3 
3 
3 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.09 
0.09 
0.09 
0.09 
0.09 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
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220 
221 
222 
223 
224 
225 
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227 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
Current Medical Research and 
opinion 
Current opinion in Pediatrics 
Diabetes care 
E-east Mediterr Health journal 
European journal of Public Health 
Experimental and clinical 
Endocrinology and Diabetes 
Experimental and clinical 
Inununogenetics 
Experimental lung research 
Expert opinion in Biological 
therupeutics 
Friologiia cheloveka 
Gaceta Medica De Mexicao 
Genes Immimology 
Genetika 
Geneomics 
Gigiena I Sanitarria 
Giomale italiano Di Medicina Del 
Lavoro Ed Ergonomia 
Heart and lung 
Hokkaido Igaku Zasshi (Jr. of 
Medical science) 
Ukrain 
U.K. 
Egypt 
Singapore 
Croatia 
Germany 
Switzerland 
U.K. 
U.K. 
Russia 
Mexico 
U.K. 
Poland 
U.S.A. 
Russia 
Italy 
U.S.A. 
Japan 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
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238 
239 
240 
241 
242 
243 
244 
245 
246 
247 
248 
249 
250 
251 
252 
253 
254 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
Hu-Nan I Ko Ta Hsuch Hsuch Pao 
Bulletin of Hunan Medical 
University 
International journal of Tuberculosis 
and lung disease 
Jou mal of clinical pharmacy and 
therapeutics 
Journal of school health 
Lijecnicki yjesnik 
Masui (Japanese Journal of 
Anesthesiology) 
Medical journal of Malaysia 
Medicine and Law 
Medical letters on drugs and 
therapeutics 
Meditsina Truda I Promyshiennaia 
Micro bes Infection 
Minerva Pediatrica 
Natural Immunity 
Nature Medicine 
Otolaryngology Head and Neck 
Surgery 
Orvosal Hetilap 
Pharmazie 
China 
France 
U.K. 
U.S.A. 
Yugoslavia 
Japan 
Mal^sia 
Israel 
U.S.A 
Russia 
Russia 
Greece 
Switzerland 
U.S.A. 
U.S.A. 
Hungry 
Germany 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
99 
255 
256 
257 
258 
259 
260 
261 
262 
263 
264 
265 
266 
161 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
41 
Practitioner 
Rinsho Byari (Japanese journal of 
clinical pathology) 
Sante 
Scottish Medical Journal 
Singapore Medical Journal 
S. African Medical Journal 
Southern Medical Journal 
Statistics in Medicine 
Toxicology 
Trends in Molecular Medicine 
Urology 
Vaccine 
Wienes Medizainische wochensch 
rift 
U.K. 
Japan 
Algeria 
Scotland 
Singapore 
S.Africa 
U.S.A. 
U.K. 
Poland 
U.K. 
U.S.A. 
U.K. 
Germany 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.06 
0.60 
0.60 
100 
Table 1.1 indicates the range of frequency occurrence of items. Five periodicals 
have their frequency occurrence of more than 100 and total number of items 
published are 784 (23.89%). The periodical having their frequency occurrence in 
range of 50-99 have 6 periodicals and the number of items pubUshed are 457 
(13.93%). In the third range 30-49 have 14 periodicals and the number of items 
pubUshed are 497 (15.14%). In the fourth range 20-29 cover 8 periodicals and the 
number of items 197 (6.0%). In the fifth range 12-19 covers 20 periodicals and the 
number of items are 266 (8.11%). So on. 
TABLE-1.1 
SHOWING RANGE OF FREQUENCY 
S.N. 
1 
2 
3 
4 
5 
6 
7 
8 
Frequaicy range 
More than 100 
50-99 
30-49 
20-29 
12-19 
6-11 
3-5 
1-2 
TOTAL = 
NO. OF 
PERIODICALS 
5 
6 
14 
8 
20 
44 
108 
261 
466 
NO. OF 
ITEMS 
784 
457 
497 
197 
266 
354 
405 
321 
3281 
%age 
23.89 
13.93 
15.14 
6.00 
8.11 
10.78 
12.34 
9.78 
99.93 
Cumulative 
%age 
23.89 
37.82 
52.96 
58.96 
67.07 
77.84 
90.15 
99.93 
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2. COUNTRY WISE DISTRIBUTION 
It is g known fact that certain countries give more research output in a 
particular subject than others. This information is very much useful, not only 
for the information managers in finalizing the subscription list of periodical 
but also for the research scholars as they tend to know the countries which 
are leaders in this field. 
Table - 2 contains list of 48 countries producing research material on 
'Asthma'. These countries have been ranked on the basis of frequency of 
occurrence of items. This analysis has revealed that 45% of articles of the 
total were published from U.S.A., This is followed by U.K., Denmark and 
Japan, \Nh\ch produce 18.4%, 5.82% and 3.35% research items 
respectively. The analysis not only shows the most potent countries of 
research on 'Asthma. But are also indicates the wide coverage of INDEX 
MEDICUS as the publication from as many as 48 countries of the world, 
have been listed. 
TABLE -2 
COUNTRY WISE DISTRIBUTION OF ITEMS 
S. No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
RANK 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
14 
15 
16 
16 
17 
18 
19 
20 
20 
Name of Country 
U.S.A. 
U.K. 
Denmark 
Japan 
Russia 
India 
China 
Poland 
France 
Germany 
Canada 
Spain 
Italy 
Mexico 
Switzerland 
Norway 
Australia 
Finland 
New Zealand 
Holland (Nether land) 
Sweden 
Ireland 
Israel 
' Frequency 
Occurrence 
1479 
604 
190 
110 
90 
84 
82 
76 
75 
73 
60 
54 
40 
31 
31 
27 
20 
20 
17 
16 
10 
8 
8 
%age 
45.07 
18.40 
5.82 
3.35 
2.74 
2.56 
2.50 
2.32 
2.29 
2.22 
1.83 
1.64 
1.22 
0.94 
0.94 
0.82 
0.61 
0.61 
0.52 
0.49 
0.30 
0.24 
0.24 
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24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
20 
21 
21 
21 
21 
22 
23 
23 
23 
23 
24 
24 
25 
25 
25 
25 
26 
26 
26 
26 
26 
26 
26 
26 
26 
South Korea 
Belgium 
Taiwan 
Thailand 
Singapore 
Yugoslavia 
Brazil 
Malaysia 
South Africa 
Tunisia 
Hungary 
Nigeria 
Algeria 
Austria 
Egypt 
Ukraine 
Argentina 
Bangladesh 
Bulgaria 
Cyprus 
Czech Republic 
Luxemt}ourg 
Portugal 
Senegal 
Zaire 
TOTAL = 
8 
6 
6 
6 
6 
5 
4 
4 
4 
4 
3 
3 
2 
2 
2 
2 
3281 
0.24 
0.18 
0.18 
0.18 
0.18 
0.15 
0.12 
0.12 
0.12 
0.12 
0.09 
0.09 
0.06 
0.06 
0.06 
0.06 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
99.89 
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Diagram No. -1 Representing Country wise Literary Output 
3. Year Wise Distribution 
Currency of information is an important factor for any good indexing 
service. The main objective of the chronological study is to find out current 
information published by Index Medicus. This study is too much useful in 
knowing the most productive year of items ranked through this study. 
Through this study ^NB know that hov\/ many articles were published in which 
year. 
Table - 3 shows the chronological scattering of all references. It give the 
number of items published in the volumes of 2001-2002 in Index Medicus 
in different years. It is to be observed that the frequency of occurrence of 
items in the volume 2001 was the highest i.e. 1493 for the same year and 
that of 2002. The frequency occurrence was 1260, which was again the 
highest for that year. However, the total percentage of the frequency of 
occurrence of items in both volumes of Index. Medicus was the highest i.e., 
45.50% in 2001. 
This is followed by 2000, 1999 and 1997 with total percentage of 
frequency of occurrence as 13.65, 0.88, 0.70 and 0.67 respectively. 
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Table - 3 YEAR WISE DISTRIBUTION OF ITEMS 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
Period 
of 
origin 
1995 
1996 
1997 
1998 
1999 
2000 
2001 
2002 
Total 
Frequency of 
occurrence of 
item in 
Volume 
-2001 
1 
4 
17 
5 
19 
29 
961 
~ 
1038 
Volume 
-2002 
-
1 
5 
18 
10 
419 
530 
1260 
2243 
Total 
Frequency 
of 
occurrence 
1 
5 
22 
23 
29 
448 
1493 
1260 
3281 
Percentage 
Frequency 
Of 
Occurrence 
0.03 
0.15 
0.67 
0.70 
0.88 
13.65 
45.50 
38.40 
99.98 
Cumulative 
Percentage 
Of 
Frequency 
0.03 
0.18 
0.85 
1.55 
2.43 
16.08 
61.58 
99.98 
107 
Diagram No. - 2 Representing year wise dlstrilaution of items 
•1995 —«—1996 —A—1997 —K—1998 —»-1999 —•—2000 —I—2001 ——2002 
4. LANGUAGE WISE DISTRIBUTION 
It is great significance for researchers to know the language in which the 
literature on their area of specialization is published. The analysis of the 
language used to transmit the subject literature is useful not only to 
under stand the coverage patterns, but also gives an indication of the 
foreign language problem likely to be faced by users. 
Table -4 shows that the total number of items (3281) were published 
in 23 different languages, out of which, English was found to be the most 
dominant language, as 2783 items constituting 84.82% were reported to 
be published in that language. The second position is occupied by 
Japanese literature in which 81 items constituting 2.47% were reported 
in two volumes of Index Medicus. The third, fourth and fifth position were 
occupied by, Russian (1.98%), French (1.92%), and Spanish (1.86%). 
About 6.95% of total literature on "Asthma" is found being published in 
other languages. Thus, the most dominate language of scientific 
communication on "Asthma" is found to be English, followed by 
Japanese, Russian, French and Spanish languages. 
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Table -4 
LANGUAGE WISEE DISTRIBUTION OF ITEMS 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
Rank 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
12 
12 
12 
13 
14 
15 
15 
16 
16 
17 
17 
Name of 
language 
English 
Japanese 
Russian 
French 
Spanish 
Chinese 
Gennan 
Polish 
Finnish 
Italian 
Swedish 
Danish 
Dutch 
Norwegian 
Roman 
Hebrew 
Hungarian 
Portuguese 
Ukrainian 
Bulgarian 
Czech 
Serbian 
Slovak 
TOTAL 
Frequency 
Occurrence 
2783 
81 
65 
63 
61 
54 
50 
43 
19 
09 
08 
06 
06 
06 
06 
05 
04 
03 
03 
02 
02 
01 
01 
3?81 
Frequency 
Occurrence 
84.82 
2.47 
1.98 
1.92 
1.86 
1.65 
1.52 
1.31 
0.58 
0.27 
0.24 
0.18 
0.18 
0.18 
0.18 
0.15 
0.12 
0.09 
0.09 
0.06 
0.06 
0.03 
0.03 
99.97 
Cumulative 
Frequency 
84.82 
87.29 
89.27 
91.19 
93.05 
94.7 
96.22 
97.53 
98.11 
98.38 
98.62 
98.80 
98.98 
99.16 
99.34 
99.49 
99.61 
99.70 
99.79 
99.85 
99.91 
99.94 
99.97 
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Diagram No. - 3 Language wise Distribution of 
Items 
84.20 
90 n 
80 
70 
60 
50 
S 40 
30 
20 
10-
0 
2.47 1.92 
8.81 
"I r — — ^ 
English Japanies Russian French Others 
Languages 
S. SUBJECT WISE DISTRIBUTION 
As we know that most of the literature on a given subject appears in 
certain core journals. This analysis has been done on the basis of subject 
field of periodicals publishing the literature. Ulrich International Periodical 
Directory (36"^  ed.) has been used to know the subject field of various 
periodicals. 
Table - 5 gives a subject break up in the field of "Asthma". It is 
observed from table-1 that all the collected items belong to different subject 
areas, which has been ranked 1 to 19 on the basis of frequency of 
occurrence of articles. The analysis shows that 36.60% of the literature 
belong to Allergy and Asthma, 18.71% belongs to Pediatric Asthma and 
5.79 belongs to Lungs- Asthma. 
TABLE - 5 
SUBJECT WISE DISTRIBUTION OF ITEMS 
S.No. 
I 
2 
3 
4 
5 
6 
Rank 
1 
2 
3 
4 
5 
6 
Subject Area 
Allergy-Asthma 
Pediatric and Asthma 
Lungs-Asthma 
Immunology &Asthma 
Epidemiology 
Genetics Asthma 
Frequency 
Occurrence 
1201 
614 
190 
170 
164 
154 
%age 
36.60 
18.71 
5.79 
5.18 
4.99 
4.69 
Cumulative 
Percentage 
36.60 
55.31 
61.1 
66.28 
71.27 
75.96 
112 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
7 
8 
9 
10 
11 
12 
13 
13 
14 
15 
15 
16 
16 
17 
18 
19 
Physio-pathology 
Enzymology &Asthma 
Microbiology & Medic. 
Asthma Therapy 
Asthma 
Nursing of Asthma 
Drug Therapy 
Occupational Asthma 
Environmental Asthma 
Chemically Induced 
Toxicology -Asthma 
Bronchial - Asthma 
Molecular Biology 
Psychological-Asthma 
Management of Asthma 
Unknown 
TOTAL = 
149 
143 
135 
130 
125 
20 
11 
11 
9 
8 
8 
7 
7 
6 
3 
16 
3281 
4.54 
4.36 
4.11 
3.96 
3.81 
0.61 
0.34 
0.34 
0.27 
0.24 
0.24 
0.21 
0.21 
0.18 
0.09 
0.48 
99.91 
80.5 
84.85 
88.96 
92.92 
96.72 
97.32 
97.65 
97.99 
98.26 
98.50 
98.74 
98.95 
99.16 
99.34 
99.43 
99.91 
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Diagram No. -4 Subjectwise Distribution of Items 
I 
J^ J^ J^ J^ ^^^ 
Subjects 
6. FORM WISE DISTRIBUTION 
Information is available in a variety of forms namely Articles, Editorial, 
Letter, News and Reviews etc. The main objective of this study is to find out 
most used form of source material. It helps the information scientists and 
their users to know the most dominant forms of documents in which 
information is being produced on the subject. 
Table - 6 gives form wise distribution of items. It was found from the 
analysis that periodicals articles are the most dominant form in which 
scientific information is communicated in 'Asthma'. It is obvious from the 
fact that 81.53% literature on the subject appeared infonn of periodical 
articles and other form of periodicals i.e. Editorial, Letters, News 
Reports, Reviews and Conference proceedings items constitute 8.02%, 
4.66%, 3.93%, and 0.49% respectively. 
This analysis may help the information scientists to decide as to 
which form of documents he has to procure in the library to meet the 
information requirements of the researchers in the field of "Asthma". 
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Table -6 FORM WISE DISTRIBUTION OF ITEMS 
S.No. 
1 
2 
3 
4 
5 
6 
Name of the form 
Articles 
Editorial 
Letters 
News Reports 
Reviews 
Conference 
Proceedings 
TOTAL 
Frequency of 
Occurrence 
2675 
263 
153 
139 
45 
16 
3281 
Frequency of 
Percentage 
81.53 
8.02 
4.66 
3.93 
1.37 
0.49 
99,99 
Cumulative 
Frequency 
81.53 
89.55 
94.21 
98.14 
99.51 
99.99 
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Diagram No. -5 Representing Form wise distribution 
of items 
90.00 
80.00 
81.53 
c^^ 
• . ^ 
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^^ .KO<^ . ^ ^ 
V 
;v^ 
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Forms 
7. RANKING OF AUTHORS 
There are certain eminent personalities in every subject, field who 
achieve recognition through their research and writing. There are a 
number of authors in every subject. However some of them are well 
known personalities in a particular subject. Therefore, it is important to 
know the eminent authors in the field of 'Asthma'. This information is 
useful for the librarians as well as users point of view. 
Table - 7 From the analysis it was found that 951 (29.27%) items 
were written by single author and 2320 (71.72%) items were written by 
multiple authors, i.e. more than one. It shows that present trends of 
research in which joint efforts are involved to complete a research work 
from limited sample such as this, it is difficult to name major contributors 
in the field. However, the present ranking list may be considerable help 
to know the names of significant authors in "Asthma". The names of first 
three productive authors are: 
(i) Stelmach, I (Frequency-21) 
(ii) Wang, G (Frequency-17) 
(iii) Park, J. K. (Frequency -15) 
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TABLE - 7 RANKING OF AUTHORS 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
RANK 
1 
2 
3 
4 
4 
5 
6 
6 
6 
6 
7 
7 
7 
7 
7 
8 
8 
8 
8 
NAME OF AUTHORS 
Stelmach, I. 
Wang, G 
Park, J.K. 
Blease, K. 
Meyer, I. H. 
Bridge, P.D. 
Banerjee, S.K. 
Holgate, S.T. 
Karila, C. 
Margurt, C. 
Myamoto, T. 
Miyazawa, R. 
Roger, G. 
Satto, Junior J.J. 
Walusiak, J. 
Barnes, P.J. 
Diaz, Jama, M. 
Huovinen, E. 
Kilpelainan, M. 
FREQUENCY 
21 
17 
15 
14 
14 
13 
12 
12 
12 
12 
11 
11 
11 
11 
11 
10 
10 
10 
10 
Cumulative 
Frequency 
21 
38 
53 
67 
81 
94 
106 
118 
130 
142 
153 
164 
175 
186 
197 
207 
217 
227 
237 
119 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
9 
9 
9 
9 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
11 
11 
11 
11 
Licchin, F. 
Nevembre, E 
Robert, G. 
Sastre, J. 
Sngawara, N. 
Wallaert, B. 
Wild, J.S. 
Wilson, A.M. 
Chu, H.W. 
Durzo, A.D. 
Goldbery, S. 
Reeves, D. 
Sears, M.R. 
Tarlo, S.M. 
Van DerWaude,H.J. 
Wassermann, K. 
Weiner, P. 
Zaas. D. 
Alamoudi, O.S. 
Conk, Crott D.W. 
Honohue, J. 
Field, S.K. 
9 
9 
9 
9 
9 
9 
9 
9 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
7 
7 
7 
7 
249 
255 
264 
273 
282 
291 
300 
309 
317 
325 
333 
341 
349 
357 
365 
373 
381 
389 
396 
403 
410 
417 
120 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
Lipworth, B.J. 
Malo, J.W. 
Noppen, M. 
Pinto, Pereira, L.M. 
Rodrigo, G.J. 
Roth, B.J. 
Sabio, J.M. 
Sin, D.D. 
Tarlo, s.M. 
Vamer, A.E. 
Wasserrmann, K. 
Baena, Cagnanic, E. 
Berenner, B.E. 
Cicuttu, B.E. 
Daley-yeates, P.T. 
Eggleston, P. A. 
Evane, D.J. 
Garcia-Marcos Alvarez, L 
Hotten, K.B. 
Halterman, J.S. 
Juhn, Y.J. 
Kanerva, L. 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
424 
431 
438 
445 
452 
459 
466 
473 
480 
487 
494 
500 
506 
512 
518 
524 
530 
536 
542 
548 
554 
560 
121 
64 
65 
66 
61 
68 
69 
70 
71 
72 
73 
74 
75 
76 
Ti 
78 
79 
80 
81 
82 
83 
84 
85 
12 
12 
12 
12 
12 
12 
13 
13 
13 
13 
13 
13 
13 
13 
13 
13 
13 
13 
13 
13 
14 
14 
Kumar, R. 
Lin, Y.Z. 
Murphy, J.C. 
Perezde Lano, L. A. 
Sabio, J.M. 
Vaszar, L.T. 
Vishal M. L. 
Ahluwalia, A. 
Beck, S.A. 
Cuddy, R. 
Holgate, S. 
Jenkin, C. 
Jungsuwade, P. 
Kisson, M. 
Krieger, B.P. 
Niimi, T. 
Ohke, M. 
Packham, S. 
Searfoue, R.J. 
Tan, K.S. 
Voilmer, W.M. 
Akinbami, L.J. 
6 
6 
6 
6 
6 
6 
6 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
4 
4 
566 
572 
578 
584 
590 
596 
601 
606 
601 
616 
621 
626 
631 
636 
641 
646 
651 
656 
661 
666 
670 
674 
122 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
H 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
15 
15 
Baushey, H. 
Bateman, ED. 
Bienakowska-Haba, M. 
Cook, C. 
De-Beraardion, C. 
Donwes, J. 
Dominguoz, Ortega, J. 
Fielder, H.M. 
Gem, J.E. 
Keeley, D. 
Li, J. 
Noguchi, E. 
Ragab, S. 
Rigoli, L. 
Singel, I.J. 
Taragin, B.H. 
Weire 
Wen, S.W. 
Yokoe, T. 
Zhang, W.P. 
Bheelue, A. 
Balkrzhanan, R. 
. . 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
3 
3 
3 
678 
682 
686 
690 
694 
698 
702 
706 
710 
714 
718 
722 
726 
730 
734 
738 
742 
746 
750 . 
753 
756 
759 
123 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
Chen, Y. 
Convery, R. 
Dhong, H.J. 
Doer, L. 
Draper, A. 
Ekici, A. 
Emelinanov, A.V. 
Emelinanov, A. 
Eliasson, M. 
Ferrer, A. 
Ford, J.G. 
Friedman, M.S. 
Fulton, J.P. 
George, M. 
Gupta. D. 
Halasz, A. 
Hashimoto, Y. 
Lemanek, K.L. 
Leshchenko, I.V. 
Li,C. 
Liang, K.Y. 
Liu, Y. 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
1 
762 
765 
768 
771 
774 
777 
780 
783 
786 
789 
792 
795 
798 
801 
804 
807 
810 
813 
816 
819 
822 
825 
124 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
Liu, X. 
Lockey, RE. 
Lorentzen, M.S. 
Massoud, M.N. 
Malmstrom, J. 
Mardiney, M. 
Mayo, P.R. 
Mergoni, M. 
MUler, R.L. 
Mitsuta, K. 
Montnemery, P. 
Naedele-Risha, R. 
Naureckas, E.T. 
Nelson, H.S. 
Neri, M. 
Nevzorova 
Nieto, A. 
0 ' Byrne, P.M. 
Ohke, M. 
Omote, T. 
Ouyang, M. 
Qiu,Z 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
828 
831 
834 
837 
840 
843 
846 
849 
852 
855 
858 
861 
864 
867 
870 
873 
876 
879 
882 
885 
888 
891 
125 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
Rannshyw, HS. 
Renz, H. 
Rutherford, R.M. 
Salpitor, D.C. 
Sandrasaga, A. 
Selverman, S. 
SheUy, M. 
Stella, M.F. 
Szczcklik, A. 
Tanaka, H. 
Taylor, D.R. 
Tunsater, A. 
Turpeinan, N. 
Valery, P.C. 
Van, Eerdewegh, D. 
Vavilian, V.A. 
VanGradfei Land, B. 
Wang, T.N. 
Wiener, P. 
Williams, D.M. 
Wothers, D.D. 
Wong, J.X. 
' • 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
894 
897 
900 
903 
906 
909 
912 
915 
918 
921 
924 
927 
930 
933 
936 
939 
942 
945 
948 
951 
954 
957 
126 
174 
175 
176 
111 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
15 
15 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
Xiao, W. 
Yamada, T. 
Zebeeolon, K. 
Zhu, L. 
Zook, J.P. 
Abay, J. 
Adaehi. T. 
Adams, R. 
Ahmad, E. F. 
Akkoe 
Alben, M. 
Al-Ghamly, Y. S. 
Al-Shadi, A.M. 
Anderson, K. 
Badr-CL-Din, O.M. 
Bagnoto, G.F. 
Barbato, A. 
Barnes, P.J. 
Barraza-villared, A. 
Basdemir, D. 
Baum, W.F. 
Beekmann, C.A. 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
960 
963 
966 
969 
971 
973 
975 
977 
979 
981 
983 
985 
987 
989 
991 
993 
995 
997 
999 
1001 
1003 
1005 
127 
196 
197 
198 
199 
200 
201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
Beimfohr, C. 
Bjermer, L. 
Borshakov, AM. 
Bqhadana, A.B. 
Brisman, J. 
Brygge, J. 
Campanella, S.A. 
Canessa, P.A. 
Gates, C. 
Chauhan, S. 
Chibana, K. 
Chukwa, C. 
Centannis 
Ciprandi, G. 
Cohn, J. 
Cordina, M. 
Crimi, E. 
Cronka, P. 
Davies, P. 
Delency, B. 
De-vaice, T.W. 
De-Zeth, R. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1007 
1009 
1011 
1013 
1015 
1017 
1019 
1021 
1023 
1025 
1027 
1029 
1031 
1033 
1035 
1037 
1039 
1041 
1043 
1045 
1047 
1049 
128 
218 
219 
220 
221 
222 
223 
224 
225 
226 
111 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
238 
239 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
Dicpinigeitis, P.V. 
Draper, A. 
Duff, A.J. 
Ecct es, M. 
Einneke, D. 
Ekiel, A. 
Eliasson, M. 
Elinaz, A. 
Farmggia, E. 
Fenech, A. 
Ferrante, P.S. 
Fnedbreg, J.J. 
Foster, P.S. 
Fuji, Y. 
Fukuda, T. 
Gausish, T.V. 
Gaylirdo, R. 
Gillisen, A. 
Gomez, J.E. 
Grzanka, A. 
Grzelewska-Rzymowska, I. 
Gupta, P.P. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1051 
1053 
1057 
1059 
1061 
1063 
1065 
1067 
1069 
1071 
1073 
1075 
1077 
1079 
1081 
1083 
1085 
1087 
1089 
1091 
1093 
1095 
129 
240 
241 
242 
243 
244 
245 
246 
247 
248 
249 
250 
251 
252 
253 
254 
255 
256 
257 
258 
259 
260 
261 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
Hara, K. 
Hari, S.P. 
Hataj, U. 
Hesselink, A.E. 
Himenel, W. 
Hole, A.M. 
Hajnes, J.M. 
Illowinte, J. 
Ishia, T.I. 
Jain, P. 
Jany, A.S. 
JefFery, P. 
Joseph, J. 
Kabra, S. 
Kannisto, S. 
Kim,M.H. 
Kimbell-Duhn, M. 
Klire, A.R.A. 
Kong, L. 
Kopinski, P. 
Kudelis, L.N. 
Kumar, R.K. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1097 
1099 
1100 
1103 
1105 
1107 
1109 
n i l 
1113 
1115 
1117 
1119 
1121 
1123 
1125 
1127 
1129 
1131 
1133 
1135 
1137 
1139 
130 
262 
263 
264 
265 
266 
267 
268 
269 
270 
271 
111 
273 
273 
274 
275 
276 
277 
278 
119 
280 
281 
282 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
Lapa-e-Silva, JR. 
Larren, C.P. 
Lasic, M. 
Lee, K.H. 
Leuppi, J.D. 
Lvpworth, B.J. 
Liss, G.M. 
Lvkases, N.W. 
Makarora, S.I. 
Marks, F. 
Mc Commeau, R. 
Mc Ghan, S.L. 
McLaren, D.S. 
Melton, L. 
Mitsut, K. 
Morice, A.M. 
Nakano, H. 
Nelson, Perey. 
Nimmi, A. 
Norzila, M.Z. 
Nystad, W. 
0 ' Connor, T.M. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1141 
1143 
1145 
1147 
1149 
1151 
1153 
1155 
1157 
1159 
1161 
1163 
1165 
1167 
1169 
1171 
1173 
1175 
1177 
1179 
1181 
1183 
131 
283 
284 
285 
286 
287 
288 
289 
290 
291 
292 
293 
294 
295 
296 
291 
298 
299 
300 
301 
302 
303 
304 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
0 ' Meill, L. 
Ohrui, T. 
Ouugonag, M. 
Park, J.W. 
Peat, J.K. 
Pitter, F.A. 
Postepski, J. 
PuUeyn, Z.J. 
QU,Z. 
Quan,B. 
Sandford, A. 
Silverman, E.S. 
Stafforini, D.M. 
Stom van's Grave Sande, K. 
Su, H.J. 
Tanihara, S. 
Teldeschi, A.L. 
Tinazero, A.M. 
Tovi-Korshynsk, M-2 
Ubaidullaev, A.M. 
Vander, Windt, D. 
Van-der powkranw, I.C. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1185 
1187 
1189 
1191 
1193 
1195 
1197 
1199 
1201 
1203 
1205 
1207 
1209 
1211 
1213 
1215 
1217 
1219 
1221 
1223 
1225 
1227 
132 
305 
306 
307 
308 
309 
310 
311 
312 
313 
314 
315 
316 
^ 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
16 
17 
' ^ 
2349 
' 
17 
Vodopian, A.V. 
Wasow-krolikoska, K. 
Weissflfoy, D. 
Wurzingel, G. 
Xiany, A. 
Xu,L. 
Yorudakul, A.S. 
Zebeecolon, K.M.C. 
Zhang, H. 
Zinchen, Ko, T.M. 
Zuveik, M. 
Alono Fernandez, A. 
^ 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1 
' ^ 
Zou, J 
r 
1 
1229 
1231 
1233 
1235 
1237 
1239 
1241 
1243 
1245 
1247 
1249 
1248 
^ r 
3281 
Note: 315 authors contributed 1247 items, are those authors who 
contributed more than 1 paper. It means, total items-items contributed by 
these authors = 3281 - 147 = 2034, no. of authors have contributed 2034 
items by contributing 1 paper each. Therefore total no. of authors = no. of 
authors, who contributed more than 1 paper + no. of authors, who 
contributed 1 paper = 1247 + 2034 = 3281. 
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Diagrame No. - 6 Representing the Authorship 
Pattern 
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APPLICATION OF BIBLIOMETRIC LAWS 
After the analysis and interpretation of data, the next step is to check 
the validity of Bibliometric laws. These are as following. 
1. BRADFORD'S LAW OF SCATTERING: 
The law states that "if scientific periodicals are arranged in order of 
decreasing productivity of articles on a given subject that may be divided 
into a nucleus of periodicals more particularly devoted to the subject and 
several groups or zones containing the same number of articles as the 
nucleus when the number of periodicals in the nucleus and succeeding 
zones will be as 1 : n : n^. 
In other words, if a group of journals are arranged in an order of 
decreasing productivity, i.e. the journal that yield the most relevant articles 
coming first and the most unproductive last, the journal will be grouped in to 
number of zones, each producing a similar number of between the zones is 
to be relevant articles the relationship be given by the following equation: 
1 : n : n^  
where 1 is the number of journals and n is a multiplier. 
On the basis of this law 466 periodicals are divided into three zones 
according to their frequency of occurrence. In the first zone, 8 periodicals 
contained 1048 of items, in the second zone 40 periodicals contained 1094 
items and remaining 418 periodical contained 1141 items in the third zone. 
In other words, we can say that firs 8 periodicals have covered 1/3 of 
the total items, next 40 periodicals have covered 1/3 items and other 418 
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periodicals also covered another 1/3 items. This data have been taken from 
Table -1 (Ranking of Periodicals). The analysis very closely shows the 
phenomena of scattering of items in different zones of journals. 
As the nucleus zone contain 8 journals followed by 40 journals in 
second zone and 418 journals in third zone. Then the three zones will form 
an approximately geometric series. 
8:40:418 
Here, 40 = 8x7 (Approx.) 
418= 8x7x7 (Approx) 
Therefore, 8: 8x7 : 8x7x7 
Substituting 4 = n 
Then we get, 8: 8n^ : 8n^ 
i.e. 1: n : n^  (where 1 is number of journals in the nucleus and n is a 
multiplier) 
Thus Bradford's law is proved. 
The number of journals in the nucleus can be obtained by plotting f 
(r) and log n on semi logarithmic graph paper (a bibliography), where f (r) is 
cumulative frequency and log n is log of rank of journals as shown In the 
graph. This graph is drawn with the help of data given in Table - 1 . 
The log value of 8 journals in the first zone is 0.9030. The log value 
of 40 journals in the second zone is 1.6020. The log value of 418 journals in 
the third zone is 2.621. 
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Taking log on X-axis and number of items in each zone on Y-axis, a 
graph was plotted. The bibliograph thus found to be similar to Bradford's 
bibliograph. The graph begins as a rising curve Ap1 and then continues as 
a straight line. The rising part of the graph represent the nucleus of highly 
productive journals. The points P1, P2 and P3 on the bibliograph are the 
boundaries of three equi-productive zones in which the same number of 
articles as the nucleus (represented by 0Y1 = Y1 Y2 = Y2 Y3) derived from 
increasingly larger number of journals (represented by 0X1, X1, X1 X2 and 
X2 X3). Thus, Bradford's law is proved. 
Table 8. Bradford's Table 
S.No. 
1 
2 
3 
4 
5 
6 
7 
8 
Total 
9 
10 
11 
12 
No. of journals 
8 
2 
2 
3 
3 
Cumulative 
journals 
1 
2 
3 
4 
5 
6 
7 
8 
10 
12 
15 
18 
No. of Items 
183 
171 
153 
147 
130 
90 
89 
83 
1046 
138 
102 
130 
HI 
Cumulative 
Items 
183 
354 
507 
654 
784 
874 
%3 
1046 
1184 
1286 
1416 
1527 
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13 
14 
15 
16 
17 
Total 
18 
19 
20 
21 
22 
23 
24 
25 
26 
Total 
4 
4 
5 
8 
9 
40 
9 
10 
15 
17 
21 
30 
55 
60 
201 
418 
22 
26 
31 
39 
48 
57 
67 
82 
99 
120 
150 
205 
265 
201 
466 
121 
118 
126 
138 
110 
1094 
106 
100 
121 
103 
105 
120 
170 
120 
201 
1141 
1648 
1766 
1892 
2030 
2140 
2246 
2346 
2467 
2570 
2675 
2795 
2%5 
3080 
3281 
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2. LOTKA'S INVERSE SQUARE LAW 
This law states that, the number of scientists who contribute n papers 
will be 1/n^  of those who contribute only one paper. 
During the present analysis it was observed that 2349 authors have 
contributed 3281 items. Out of 2349 authors only 315 authors have 
contributed more than one paper and rest 2034 authors contributed one 
paper each i.e. single contribution. 
However, according to Lotka's law, single contributors should 
account for 60% of the total. Lotka's law was applied to know the number of 
scientists contributing 2 papers, 3 papers and 4 papers respectively, as 
given below: 
2.1 SCIENTISTS CONTRIBUTING TWO PAPERS 
As we know that the number of authors contributing one paper 2034, 
therefore the number of scientists contributing 2 papers may be calculated 
by formula: 
No. of scientists publishing 1 paper 
No. of scientists publishing n papers = 
n^  
2034 2034 
No. of scientists publishing 2papers = = = 508.5 
2' 4 
An analysis of the actual data shows that only 140 authors have 
contributed 2 papers, \tA\\ch is far less than the 508.5 figures obtained by 
applying Lotka's law. 
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2.2 SCIENTISTS CONTRIBUTING THREE PAPERS 
Applying the formula: 
No. of Scientists publishing n papers = No. of Scientists publishing 1 paper 
n^  
2034 2034 
No. of Scientists publishing 3 papers = = = 226 
3^  
During the analysis it was found that only 71 authors contributed 3 papers 
each, 
Which is far less than 226. 
2.3 SCIENTISTS CONTRIBUTING FOUR PAPERS 
Applying the formula 
No. of scientists publishing 1 paper 
No. of scientists publishing n papers = 
n^  
2034 2034 
No. of scientists publishing 2papers = = =127.13 
4^  16 
The analysis of the actual data shows that only 21 authors contribute 
4 papers which is again far less than calculated figure 127.13 
It may be therefore concluded that the trends of research now a day 
have changed as compared to the period when Lotka's law was fonnulated. 
This is why it is not possible to testify the Lotka's Law, on the basis of 
analysis of the present data. 
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3. Zipf s LAW OF WORD OCCURRENCE 
This law states that "in long textual matter if words are arranged 
in their decreasing order of frequency, in the ranking of any given word of 
the text will be inversely proportional to frequency of occurrence of the 
words". So in this system it is very difficult to arrange the laws. 
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CONCLUSION AND IMPLICATIONS 
Bibliometrics has established as the most active field of library and 
information science during the past few decades. The statistical and 
analytical methods of Bibliometric study are very useful to eliminate low 
quality literature and to sort out the significant and reliable publications. It is 
also useful for making the acquisition policy and in providing better services 
to patrons and knowing the location of materials. To differentiate the 
properties and trends of the literature on "Asthma" a bibliometric study 
was conducted for the purpose 'INDEX MEDICUS' was consulted as source 
documents for getting the required data. The field of "Asthma" is a field of 
Medicine, which deals with the study of Chronic illness with the aids of 
scientific methodology. 
The basic objective of bibliometric study are as follows: 
1. to compile a ranked list of journals. 
2. to find out the individual contribution of significant authors and 
observe authorship pattern. 
3. to distribute dted serials according to their country of origin 
and languages. 
4. to find out the form of the documents used in the subject fields. 
5. to observe chronological distribution and frequency of cited 
journals. 
Table -1 Shows the ranking of 466 journals. The most 
productive periodicals in the field of 'Asthma' are: 
i. Journal of Allergy and Clinical immunology - 183 
(5.58%) 
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ii. American journal of respiratory and critical care 
medicine. 171 (5.22%) 
iii. Chest-153 (4.66%) 
iv. Annals of Allergy, Asthma and immunology - 147 
(4.48%) 
V. Thorax-130 (3.96%) 
This study will help the librarian in deciding as to which periodicals 
on the subjects Asthma may be subscribed in the library. 
Table-2.Shows the geographical scattering of items. The literary 
output of USA is maximum as compared to other countries, as it account for 
45.07% of the total data . The 2"**, 3"^ , 4* and 5* position were occupied by 
UK (18.40%), Denmark (5.82%), Japan (3.35%) and Russia (2.74%) 
respectively. Table shows that 48 countries are producing literature on the 
subject Asthma. It indicates the wide range of the source document with the 
help of this study one can get the idea about the most productive country in 
the field of 'Asthma'. 
Table - 3 shows the year wise distribution of items. This table shows 
that maximum number of items have originated during the year 2001 
(45.50%) . the other productive year are 2002 (38.40%) and 2000 
(13.65%). This information is being published in 'INDEX MDICUS'. 
Table -4 Shows that 84.82% literature in the field of Asthma, is published 
in English language. About 15.12% literature on the 'Asthma' is being 
published in other languages such as Japanese (2.47%), Russia (1.98%), 
and French (1.92%). With the help of this study we will be know about the 
most productive language in the field of 'Asthma'. 
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Table -5 shows the subject wise distribution of items. This table shows that 
36.6% literature belong to Allergy-Asthma and 63.4% literature is scattered 
in other disciplines like Pediatric Asthma , Genetics Asthma and so on. 
Table - 6 shows the form wise distribution of items. This analysis reveals 
that most dominant form in the field of 'Asthma' . The foremost conclusion 
drawn from table 6 is that world output is dominated by periodical articles 
81.53% of the total data was found to be in form of articles. 
Table -7 shows the ranking of authors. From this analysis it was found 
2312 items were contributed by more than one author and 931 by single 
author. From Table -7 following eminent personalities in the subject under 
the study, were found : 
i. Stelmach, I. (Frequency-21) 
ii. Wang, G. (Frequency-17) 
iii Park, J.K. (Frequency - 15) 
The ranking of authors shows the recent trends of research in the subject 
'Asthma'. 
At last the Bibliometric laws such as Bradford's, and Lotka's law have been 
applied. Among them Bradford's law have been testified as they are still 
valid today. But Lotka's law could not be testified probably because of the 
changing trends of research in modern era. 
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